Xin Shelley Wang, MD, MPH

Peer-Reviewed Articles

1. Chang E, Holliday EB, Szklaruk J, Erwin WD, Ludmir EB, Noticewala SS, Das P, Koong AC, Minsky BD, Smith GL, Sawakuchi GO, Martin-Paulpeter RM, Niedzielski JS, Perles LA, Beddar S, Raghav KP, Javle M, Kaseb AO, Dasari AN, Overman MJ, Parseghian CM, Odisio BC, Mahvash A, Kuban JD, Shen S, Wang XS, Gupta AC, Al Taie MM, Brock KK, Tzeng CD, Vauthey J, Wong FC, Koay EJ. Single Photon Emission Computed Tomography Functional Liver Imaging to Facilitate Reirradiation for Liver Malignancies: A Phase I Trial. JHEP Reports 8(4), 2026. e-Pub 2026.
2. Marincola Smith, P, Tomita, K, Cass, SH, Hirata, Y, Pan, C, Shen, SE, Wang, X, Wang, XS, Williams, LA, Arvide, M, To, C, Rajaram, R, Rice, DC, Hofstetter, WL, Antonoff, MB, Mehran, RJ, Vaporciyan, AA, Walsh, GL, Maxwell, JE, Snyder, RA, Kim, M, Tzeng, CD, Badgwell, BD, Mansfield, PF, Katz, MH, Swisher, SG, Lee, JE, Ikoma, N. Psychometric Validation of a new module of MD Anderson Symptom Inventory (MDASI) for Patients with Upper Gastrointestinal Cancers. Annals of surgical oncology 33(2):1332-1342, 2026. e-Pub 2026. PMID: 41057745.
3. Ren S, Tan Y, Xu H, Wang M, Xiang R, Jin J, Han B, Shi J, Zhang J, Yang J, Tian X, Li Y, Chen J, Zhang W, Yang J, Wang XS, Shi Q, Liu J. Long-Term Symptom Burden in a Young, Ambulatory Cohort after the Omicron Outbreak Infected Ambulatory Patients after Omicron Outbreak in China. Frontiers in Public Health, section Infectious Diseases: Epidemiology and Prevention. e-Pub 2025.
4. Wang, XS, Blum Murphy, M, Shen, SE, Letona, E, Noor, L, Cleeland, C. Defining critical symptom parameters for an ePRO-based management pathway during systemic treatment for advanced upper gastrointestinal cancer. Quality of Life Research 34(11):3181-3190, 2025. e-Pub 2025. PMID: 41071443.
5. Ikoma N, Grotz T, Kawakubo H, Kim H, Matsuda S, Okui J, Tomita K, Hirata Y, Nakao A, Williams LA, Wang XS, Wang X, Mansfield PF, Hyung W, Badgwell BD, Strong VE, Kitagawa Y. Transpacific multicenter collaborative study of minimally invasive proximal gastrectomy vs. minimally invasive total gastrectomy for proximal gastric and gastroesophageal junction cancers: 3-month follow-up results. Surgical Endoscopy 39(12):8371-8384, 2025. e-Pub 2025. PMID: 41023216.
6. Wang XS, Cleeland CS. Role of patient-reported outcomes in geriatric oncology research and patient care. Holistic Integrative Oncology 4(1):1-4, 2025. e-Pub 2025.
7. Wang XS, Murphy MB, Shen S, Letona E, Noor L, Cleeland CS. Defining critical symptom parameters for an ePRO-based management pathway during systemic treatment for advanced upper gastrointestinal cancer: a longitudinal study. Quality of Life Research. e-Pub 2025.
8. Smith PM, Cass SH, Pan C, Shen S, Wang XS, Wang X, Arvide E, To C, Rajaram R, Rice D, Hofstetter W, Antonoff M, Mehran RJ, Vaporciyan AA, Mansfield PF, Katz MH, Lee JE, Swisher SG. Psychometric Validation of a new module of MD Anderson Symptom Inventory (MDASI) for Patients with Upper Gastrointestinal Cancers: MDASI-UGI-Surg. Annals of Surgical Oncology. e-Pub 2025.
9. Iniesta-Donate, M, Ramirez, PT, Munsell, M, Basabe, S, Shen, SE, Cain, K, Shafer, A, Lasala, J, Mena, GE, Wang, XS, Cohen, L, Meyer, LA. Integration of self-hypnosis in an enhanced recovery after surgery program in gynecologic oncology – A prospective randomized trial. Gynecologic oncology 198:96-103, 2025. e-Pub 2025. PMID: 40466319.
10. Ren, S, Tan, Y, Xu, HK, Wang, M, Xiang, R, Jin, J, Han, B, Shi, J, Zhang, J, Yang, J, Tian, X, Li, Y, Chen, J, Zhang, W, Yang, J, Wang, XS, Shi, Q, Liu, J. Long-term symptom burden in a young, ambulatory cohort after the omicron outbreak in China. Frontiers in Public Health 13, 2025. e-Pub 2025. PMID: 41487644.
11. Kamal Jomaa, M, Shi, Q, Shen, SE, Cleeland, C, Wang, XS. Trajectory, interactions, and predictors of higher symptom burden during induction therapy for multiple myeloma. Journal of Patient-Reported Outcomes 8(1), 2024. e-Pub 2024. PMID: 39630196.
12. Andring, L, Corrigan, KL, Reeve, BB, Meyer, LA, Wang, XS, Smith, GL, Bailard, NS, Domingo, M, Fellman, B, Varkey, J, Foster-Mills, T, Lin, L, Jhingran, A, Colbert, LE, Eifel, PJ, Klopp, AH, Joyner, MM. The Value of Patient-Reported Outcomes to Predict Symptom Burden and Health-Related Quality of Life After Chemoradiation for Cervical Cancer. Practical radiation oncology 14(5):e353-e361, 2024. e-Pub 2024. PMID: 38825227.
13. Cass, SH, Williams, LA, Rajaram, R, Hirata, Y, Rice, DC, Tzeng, CD, Katz, MH, Badgwell, BD, Wang, XS, Ikoma, N. Patient-reported outcome measures in surgical patients with upper gastrointestinal cancers. Journal of surgical oncology 130(1):117-124, 2024. e-Pub 2024. PMID: 38798277.
14. Wang, XS, Shi, Q, Shen, SE, Letona, E, Kamal Jomaa, M, Cleeland, C, Aloia, TA, Gottumukkala, V. Patient-reported outcomes after oncologic hepatic resection predict the risk of delayed readiness to return to intended oncologic therapy (RIOT). European Journal of Surgical Oncology 50(7), 2024. e-Pub 2024. PMID: 38754314.
15. Cleeland CS, Keating KN, Cuffel B, Elbi C, Siegel JM, Gerlinger C, Symonds T, Sloan JA, Dueck AC, Bottomley A, Wang XS, Williams LA, Mendoza TR. Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma. Sci Rep 14(1):14839, 2024. e-Pub 2024. PMID: 38937473.
16. Dai W, Wang Y, Liao J, Wei X, Dai Z, Xu W, Liu Y, Wang XS, Pompili C, Yu H, Pu Y, Zhao Y, Cao B, Wang Q, Feng W, Zhang Y, Liu F, Deng Y, Zhou J, Li J, Xie S, Xiang R, Wang X, Tian B, Yang X, Hu B, Liu X, Xie T, Yang X, Zhuang X, Qiao G, Li Q, Shi Q. Electronic Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized, Controlled Trial. J Clin Oncol 42(18):2126-2131, 2024. e-Pub 2024. PMID: 38574304.
17. Chung, M, Chen, TH, Wang, XS, Kim, KH, Abdi, S. The impact of scrambler therapy on pain and quality of life for chemotherapy-induced peripheral neuropathy. Pain Practice 24(5):749-759, 2024. e-Pub 2024. PMID: 38418433.
18. Huepenbecker, S, Iniesta, MD, Wang, XS, Cain, K, Zorrilla-Vaca, A, Shen, SE, Basabe, M, Suki, T, Garcia-Lopez, J, Mena, GE, Lasala, J, Williams, LA, Ramirez, PT, Meyer, LA. Longitudinal perioperative patient-reported outcomes in open compared with minimally invasive hysterectomy. American journal of obstetrics and gynecology 230(2):241.e1-241.e18, 2024. e-Pub 2024. PMID: 37827271.
19. Jackson-Carroll, N, Johnson, CM, Tawbi, H, Wang, XS, Whisenant, M. The Symptom Experience of Patients with Advanced Melanoma Undergoing Immune Checkpoint Inhibitor (ICI) Therapy. Seminars in oncology nursing 40(1), 2024. e-Pub 2024. PMID: 38220519.
20. Walsh, S, Wang, K, Lam, A, Du, S, Hu, Y, Sun, YT, Tcharkhedian, E, Nikas, E, Webb, G, Moylan, E, Della-Fiorentina, S, Fahey, P, Wang, XS, Chen, M, Zhu, X. Baduanjin Mind-Body Exercise for Cancer-Related Fatigue. Integrative cancer therapies 23, 2024. e-Pub 2024. PMID: 38317410.
21. Li X, Wang XS, Huang H, Liu M, Wu Y, Qiu J, Zhang B, Cui L, Hui D. National survey on the availability of oncology palliative care services at tertiary general and cancer hospitals in China. BMC Palliat Care 22(1):144, 2023. e-Pub 2023. PMID: 37770965.
22. Ikoma N, Grotz T, Kawakubo H, Kim HI, Matsuda S, Hirata Y, Nakao A, Williams LA, Wang XS, Mendoza T, Wang X, Badgwell BD, Mansfield PF, Hyung WJ, Strong VE, Kitagawa Y. Trans-pacific multicenter collaborative study of minimally invasive proximal versus total gastrectomy for proximal gastric and gastroesophageal junction cancers. BMC Surg 23(1):262, 2023. e-Pub 2023. PMID: 37653380.
23. Liu J, Yu Q, Wang XS, Shi Q, Wang J, Wang F, Ren S, Jin J, Han B, Zhang W, Su X, Yuan S, Lin H. Compound Kushen Injection Reduces Severe Toxicity and Symptom Burden Associated With Curative Radiotherapy in Patients With Lung Cancer. J Natl Compr Canc Netw 21(8):821-830.e3, 2023. e-Pub 2023. PMID: 37549911.
24. Wang XS, Bree KK, Navai N, Kamal M, Shen SE, Letona E, Cleeland CS, Shi Q, Gottumukkala V. Utility of Patient-Reported Symptom and Functional Outcomes to Indicate Recovery after First 90 Days of Radical Cystectomy: A Longitudinal Study. Cancers (Basel) 15(11), 2023. e-Pub 2023. PMID: 37297013.
25. Tang L, Yu H, Dai W, Yang X, Wei X, Wang XS, Cleeland CS, Li Q, Shi Q. Symptom Trajectories Informing Patient Care After Lung Cancer Surgery: A Longitudinal Patient-Reported Outcome Study. Ann Surg Oncol 30(5):2607-2617, 2023. e-Pub 2023. PMID: 36658248.
26. Wang XS, Srour SA, Mendoza T, Whisenant M, Subbiah I, Gonzalez E, Kamal M, Shen SE, Cleeland C, Kebriaei P, Rezvani K, Neelapu S, Ahmed S, Shpall E. Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy. Br J Haematol 201(4):738-746, 2023. e-Pub 2023. PMID: 36733986.
27. Tang L, Yu H, Dai W, Yang X, Wei X, Wang XS, Cleeland CS, Li Q, Shi Q. ASO Visual Abstract: Symptom Trajectories Informing Patient Care After Lung Cancer Surgery: A Longitudinal Patient-Reported Outcome Study. Ann Surg Oncol 30(5):2618-2619, 2023. e-Pub 2023. PMID: 36847956.
28. Wang XS, Ramirez PT, Shi Q, Kamal M, Garcia-Gonzalez A, Iniesta MD, Cleeland CS, Meyer LA. Patient-reported symptoms at discharge and risk of complications after gynecologic surgery. Int J Gynecol Cancer 33(2):271-277, 2023. e-Pub 2023. PMID: 36600503.
29. Piccinin C, Basch E, Bhatnagar V, Calvert M, Campbell A, Cella D, Cleeland CS, Coens C, Darlington AS, Dueck AC, Groenvold M, Herold R, King-Kallimanis BL, Kluetz PG, Kulis D, O'Connor D, Oliver K, Pe M, Reeve BB, Reijneveld JC, Wang XS, Bottomley A. Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: Findings from an international, multidisciplinary working group. Lancet Oncol 24(2):e86-e95, 2023. e-Pub 2023. PMID: 36725153.
30. Zorrilla-Vaca A, Ramirez PT, Iniesta-Donate M, Lasala JD, Wang XS, Williams LA, Meyer L, Mena GE. Opioid-sparing anesthesia and patient-reported outcomes after open gynecologic surgery: a historical cohort study. Can J Anaesth 69(12):1477-1492, 2022. e-Pub 2022. PMID: 36224506.
31. Zhang J, Su X, Xu W, Yu Q, Dai W, Wang Y, Zhuang X, Li Q, Wang XS, Shi Q. Identifying patients who suffered from post-discharge cough after lung cancer surgery. Support Care Cancer 30(9):7705-7713, 2022. e-Pub 2022. PMID: 35695932.
32. Xu W, Dai W, Gao Z, Wang XS, Tang L, Pu Y, Yu Q, Yu H, Nie Y, Zhuang W, Qiao G, Cleeland CS, Shi Q. Establishment of Minimal Clinically Important Improvement for Patient-Reported Symptoms to Define Recovery After Video-Assisted Thoracoscopic Surgery. Ann Surg Oncol 29(9):5593-5604, 2022. e-Pub 2022. PMID: 35368219.
33. Kamal M, Navai N, Bree KK, Williams LA, Cleeland CS, Shen SE, Wang XS. Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting. Cancers (Basel) 14(16):3896, 2022. e-Pub 2022. PMID: 36010890.
34. Xu W, Dai W, Gao Z, Wang XS, Tang L, Pu Y, Yu Q, Yu H, Nie Y, Zhuang W, Qiao G, Cleeland CS, Shi Q. Correction to: Establishment of Minimal Clinically Important Improvement for Patient-Reported Symptoms to Define Recovery After Video-Assisted Thoracoscopic Surgery. Ann Surg Oncol 29(8):4923, 2022. e-Pub 2022. PMID: 35415818.
35. Xue D, Li P, Chen TH, Shi Q, Wang XS. Utility of a Patient-Reported Symptom and Functioning Assessment Tool for Geriatric Oncology Care in China. Value Health Reg Issues 29:28-35, 2022. e-Pub 2022. PMID: 34801883.
36. Dai W, Feng W, Zhang Y, Wang XS, Liu Y, Pompili C, Xu W, Xie S, Wang Y, Liao J, Wei X, Xiang R, Hu B, Tian B, Yang X, Wang X, Xiao P, Lai Q, Wang X, Cao B, Wang Q, Liu F, Liu X, Xie T, Yang X, Zhuang X, Wu Z, Che G, Li Q, Shi Q. Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial. J Clin Oncol 40(9):988-996, 2022. e-Pub 2022. PMID: 34995100.
37. Xiao W, Chan CWH, Wang XS, Xiao J, Ng MSN. Psychometric validation of the Chinese version of the M. D. Anderson Symptom Inventory-Head and Neck Module in patients with nasopharyngeal carcinoma. Asia Pac J Oncol Nurs 9(2):113-118, 2022. e-Pub 2022. PMID: 35529413.
38. Yu Q, Yu H, Xu W, Pu Y, Nie Y, Dai W, Wei X, Wang XS, Cleeland CS, Li Q, Shi Q. Shortness of Breath on Day 1 After Surgery Alerting the Presence of Early Respiratory Complications After Surgery in Lung Cancer Patients. Patient Prefer Adherence 16(709-722):709-722, 2022. e-Pub 2022. PMID: 35340757.
39. Whisenant, M, Srour, S, Williams, LA, Subbiah, IM, Griffin, D, Ponce, D, Kebriaei, P, Neelapu, SS, Shpall, E, Ahmed, S, Wang, XS. The Unique Symptom Burden of Patients Receiving CAR T-Cell Therapy. Seminars in oncology nursing 37(6), 2021. e-Pub 2021. PMID: 34629213.
40. Wang XS, Gottumukkala V. Patient-reported outcomes: Is this the missing link in patient-centered perioperative care?. Best Pract Res Clin Anaesthesiol 35(4):565-573, 2021. e-Pub 2021.
41. Xue D, Li P, Chen TH, Shi Q, Wang XS. Utility of a Patient-Reported Symptom and Functioning Assessment Tool for Geriatric Oncology Care in China. Health Reg Issues. Value Health Reg Issues 29:28-35, 2021. e-Pub 2021.
42. Wang XS, Srour SA, Whisenant M, Subbiah IM, Chen TH, Ponce D, Gonzalez AG, Kamal M, Mendoza T, Cleland CS, Kebriaei P, Neelapu SS, Rezvani K, Ahmed S, Shpall E. Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies. Transplant Cell Ther 27(11):930e1-930.e10, 2021. e-Pub 2021. PMID: 34265479.
43. Westerman ME, Bree KK, Kokorovic A, Frank J, Wang XS, Kamat AM, Dinney CPN, Navai N. What Women Want: Radical Cystectomy and Perioperative Sexual Function Educational Needs. Urology 157:181-187, 2021. e-Pub 2021. PMID: 34186127.
44. Wang XS, Cleeland CS. Cancer-Related Fatigue: What we have learned and what are the challenges for the future. J Cancer Rehabil 4:308-312, 2021. e-Pub 2021.
45. Wang XS, Shi Q, Mendoza TR, Garcia-Gonzalez A, Chen TY, Kamal M, Chen TH, Heijnen C, Orlowski RZ, Cleeland CS. Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial. Support Care Cancer 29(10):6099-6107, 2021. e-Pub 2021. PMID: 33792800.
46. Zhang T, Zheng YY, Yang ZR, Shi Q, Wang XS, Zhao J, Yang M, Wu CL, Wang GR. Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer. BMC Women's Health 21(1):276, 2021. e-Pub 2021. PMID: 34325677.
47. Huepenbecker S, Hillman RT, Iniesta MD, Chen T, Cain K, Mena G, Lasala J, Wang XS, Williams L, Taylor JS, Lu KH, Ramirez PT, Meyer LA. Impact of a tiered discharge opioid algorithm on prescriptions and patient-reported outcomes after open gynecologic surgery. Int J Gynecol Cancer 31(7):1052-1060, 2021. e-Pub 2021. PMID: 34135073.
48. Wang XS, Shi Q, Williams LA, Lillemoe HA, Chen TY, Gottumukkala V, Garcia-Gonzalez A, Malveaux D, Kamal M, Cleeland CS, Aloia TA. Development of a Patient-Reported Outcome Tool for Assessing Symptom Burden during Perioperative Care in Liver Surgery: The MDA SI-PeriOp-Hep. Eur J Oncol Nurs 52:101959, 2021. e-Pub 2021. PMID: 33964632.
49. Kamal M, Joseph J, Greenbaum U, Hicklen R, Kebriaei P, Srour SA, Wang XS. Patient-Reported Outcomes for Cancer Patients with Hematological Malignancies Undergoing Chimeric Antigen Receptor T-Cell Therapy: A Systematic Review. Transplant Cell Ther 27(5):390.e1-390.e7, 2021. e-Pub 2021. PMID: 33965176.
50. Huang S, Zhuang W, Wang D, Zha L, Xu X, Li X, Shi Q, Wang XS, Qiao G. Persistent Somatic Symptom Burden and Sleep Disturbance in Patients with COVID-19 During Hospitalization and After Discharge: A Prospective Cohort Study. Med Sci Monit 27:e930447, 2021. e-Pub 2021. PMID: 33854028.
51. Wang XS, Kamal M, Chen TH, Shi Q, Garcia-Gonzalez A, Iniesta MD, Cleeland CS, Gottumukkala V, Meyer LA. Assessment of physical function by subjective and objective methods in patients undergoing open gynecologic surgery. Gynecol Oncol 161(1):83-88, 2021. e-Pub 2021. PMID: 33536127.
52. Zhi WI, Gentile D, Diller M, Kinney A, Bao T, Master V, Wang XS. Patient-Reported Outcomes of Pain and Related Symptoms in Integrative Oncology Practice and Clinical Research: Evidence and Recommendations. Oncology (Williston Park) 35(1):35-41, 2021. e-Pub 2021. PMID: 33443769.
53. Meyer LA, Corzo C, Iniesta MD, Munsell M, Shi Q, Pitcher B, Lasala J, Cain KE, Wang XS, Mena G, Ramirez PT. A prospective randomized trial comparing liposomal bupivacaine vs standard bupivacaine wound infiltration in open gynecologic surgery on an enhanced recovery pathway. Am J Obstet Gynecol 224(1):70.e1-70.e11, 2021. e-Pub 2021. PMID: 32682856.
54. Kamal M, Wang XS, Shi Q, Zyczynski TM, Davis C, Williams LA, Lin HK, Garcia-Gonzalez A, Cleeland CS, Orlowski R. Symptom burden and its functional impact in patients with "symptomatic" relapsed or refractory multiple myeloma. Support Care Cancer 29(1):467-475, 2021. e-Pub 2021. PMID: 32390093.
55. Wang XS, Kamal M, Chen TH, Shi Q, Garcia-Gonzalez A, Iniesta M, Cleeland C, Gottumukkala V, Meyer L. Assessment of Physical Function by Subjective and Objective Methods in Patients Undergoing Open Gynecologic Surger. Gynecologic Oncology 161(1):83-88, 2021. e-Pub 2021.
56. Hillman RT, Iniesta MD, Shi Q, Suki T, Chen T, Cain K, Williams L, Wang XS, Taylor JS, Mena G, Lasala J, Ramirez PT, Meyer LA. Longitudinal patient-reported outcomes and restrictive opioid prescribing after minimally invasive gynecologic surgery. Int J Gynecol Cancer 31(1):114-121, 2021. e-Pub 2021. PMID: 33158876.
57. Westerman ME, Kokorovic A, Wang XS, Lim A, Garcia-Gonzalez A, Seif M, Wang R, Kamat AM, Dinney CPN, Navai N. Radical Cystectomy and Perioperative Sexual Function: A Cross-Sectional Analysis. J Sex Med 17(10):1995-2004, 2020. e-Pub 2020. PMID: 32713807.
58. Shi Q, Lee JW, Wang XS, Fisch MJ, Chang VT, Wagner L, Cleeland CS. Testing Symptom Severity Thresholds and Potential Alerts for Clinical Intervention in Patients With Cancer Undergoing Chemotherapy. JCO Oncol Pract 16(9):JOP1900403, 2020. e-Pub 2020. PMID: 32369412.
59. Xu Y, Wang XS, Chen Y, Shi Q, Chen TH, Li P. A Phase II Randomized Controlled Trial of Renshen Yangrong Tang Herbal Extract Granules for Fatigue Reduction in Cancer Survivors. J Pain Symptom Manage 59(5):966-973, 2020. e-Pub 2020. PMID: 31668965.
60. Kamal M, Wang XS, Shi Q, Mendoza T, Garcia-Gonzalez A, Bokhari RH, Cleeland CS, Fogelman DR. A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients with Advanced Pancreatic Cancer. J Pain Symptom Manage 59(5):1052-1058.e1, 2020. e-Pub 2020. PMID: 31982605.
61. Advani SM, Shi Q, Overman MJ, Loree JM, Lam M, Morris V, Shureiqi I, Kee B, Dasari A, Vilar E, Sarshekeh AM, Lin HK, Manuel S, Hamilton S, Raghav K, Maru D, Kopetz S, Wang XS. Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal Cancer. Clin Colorectal Cancer 19(1):48-56.e2, 2020. e-Pub 2020. PMID: 32008976.
62. Mendoza TR, Williams LA, Shi Q, Wang XS, Bamidele O, Woodruff JF, Cleeland CS. The Treatment-induced Neuropathy Assessment Scale (TNAS): a psychometric update following qualitative enrichment. J Patient Rep Outcomes 4(1):15, 2020. e-Pub 2020. PMID: 32076879.
63. Wang XS, Shi Q, Mendoza T, Lin S, Chang JY, Bokhari RH, Lin HK, Garcia-Gonzalez A, Kamal M, Cleeland CS, Liao Z. Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial. Int J Radiat Oncol Biol Phys 106(1):100-107, 2020. e-Pub 2020. PMID: 31627177.
64. Gunn GB, Mendoza TR, Garden AS, Wang XS, Shi Q, Morrison WH, Frank SJ, Phan J, Fuller CD, Chambers MS, Hanna EY, Lu C, Rosenthal DI, Cleeland CS. Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Support Care Cancer 28(1):261-269, 2020. e-Pub 2020. PMID: 31037378.
65. Lillemoe HA, Marcus RK, Kim BJ, Narula N, Davis CH, Shi Q, Wang XS, Aloia TA. Severe Preoperative Symptoms Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection. Ann Surg Oncol 26(13):4548-4555, 2019. e-Pub 2019. PMID: 31414293.
66. Xu Y, Wang XS, Chen Y, Shi Q, Chen TH, Li P. A Phase II Randomized Controlled Trial of Renshen Yangrong Tang Herbal Extract Granules for Fatigue Reduction in Cancer Survivors Journal of Pain and Symptom Management. J Pain Symptom Manage 59(5):966-973. e-Pub 2019. PMID: 31668965.
67. Wang XS, Shi Q, Bhadkamkar NA, Cleeland CS, Garcia-Gonzalez A, Aguilar JR, Heijnen C, Eng C. Minocycline for Symptom Reduction During Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial. J Pain Symptom Manage 58(4):662-71, 2019. e-Pub 2019. PMID: 31254639.
68. Liu J, Mao JJ, Wang XS, Lin H. Evaluation of Traditional Chinese Medicine Herbs in Oncology Clinical Trials. Cancer J 25(5):367-371, 2019. e-Pub 2019. PMID: 31567465.
69. Head MD, Working Group NCS, Grant S, Kamal M, Mohamed ASR, Zaveri J, Barrow MP, Gunn GB, Lai SY, Lewin JS, Rosenthal DI, Wang XS, Fuller CD, Hutcheson KA. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing. Cancer 125(10):1654-1664, 2019. e-Pub 2019. PMID: 30633325.
70. Meyer LA, Shi Q, Lasala J, Iniesta MD, Lin HK, Nick AM, Williams L, Sun C, Wang XS, Lu KH, Ramirez PT. Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery. Gynecol Oncol 152(3):501-508, 2019. e-Pub 2019. PMID: 30876495.
71. Wang XS, Shi Q, Williams LA, Cleeland CS, Garcia-Gonzalez A, Chen TY, Shahid DR, Ramirez PT, Iniesta MD, Siverand AM, Meyer LA. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN). Gynecol Oncol 152(3):492-500, 2019. e-Pub 2019. PMID: 30876494.
72. Meyer LA, Lasala J, Iniesta MD, Nick AM, Munsell MF, Shi Q, Wang XS, Cain KE, Lu KH, Ramirez PT. Effect of an enhanced recovery after surgery program on opioid use and patient-reported outcomes. Obstet Gynecol 132(2):281-290, 2018. e-Pub 2018. PMID: 29995737.
73. Yue J, Shi Q, Xu T, Jeter M, Chen TY, Komaki R, Gomez DR, Pan T, Cleeland CS, Liao Z, Wang XS. Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study. Qual Life Res 27(6):1563-1570, 2018. e-Pub 2018. PMID: 29549533.
74. Kukreja JB, Shi Q, Chang CM, Seif MA, Sterling BM, Chen TY, Creel KM, Kamat AM, Dinney CP, Navai N, Shah JB, Wang XS. Patient-reported outcomes are associated with enhanced recovery status in patients with bladder cancer undergoing radical cystectomy. Surg Innov 25(3):242-250, 2018. e-Pub 2018. PMID: 29557251.
75. Shah N, Shi Q, Giralt S, Williams L, Bashir Q, Qazilbash M, Champlin RE, Cleeland CS, Wang XS. Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma. Qual Life Res 27(4):979-985, 2018. e-Pub 2018. PMID: 29260444.
76. Deng G, Giralt S, Chung DJ, Landau H, Siman J, Search B, Coleton M, Vertosick E, Shapiro N, Chien C, Wang XS, Cassileth B, Mao JJ. Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial. Support Care Cancer 26(2):657-665, 2018. e-Pub 2018. PMID: 28920142.
77. Li Z, Shi Q, Liu M, Jia L, He B, Yang Y, Liu J, Lin H, Lin HK, Li P, Wang XS. Validation and application of the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM). J Natl Cancer Inst Monogr 2017(52):48-57, 2017. e-Pub 2017. PMID: 29140491.
78. Zia FZ, Olaku O, Bao T, Berger A, Deng G, Yin Fan A, Garcia MK, Herman PM, Kaptchuk TJ, Ladas EJ, Langevin HM, Lao L, Lu W, Napadow V, Niemtzow RC, Vickers AJ, Shelley Wang X, Witt CM, Mao JJ. The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps. J Natl Cancer Inst Monogr 2017(52):68-73, 2017. e-Pub 2017. PMID: 29140486.
79. Aloia TA, Kim BJ, Segraves-Chun YS, Cata JP, Truty MJ, Shi Q, Holmes A, Soliz JM, Popat KU, Rahlfs TF, Lee JE, Wang XS, Morris JS, Gottumukkala VNR, Vauthey JN. A randomized controlled trial of postoperative thoracic epidural analgesia versus intravenous patient-controlled analgesia after major hepatopancreatobiliary surgery. Ann Surg 266(3):545-554, 2017. e-Pub 2017. PMID: 28746153.
80. Fogelman DR, Morris J, Xiao L, Hassan M, Vadhan S, Overman M, Javle S, Shroff R, Varadhachary G, Wolff R, Vence L, Maitra A, Cleeland C, Wang XS. A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients. Support Care Cancer 25(6):1809-1817. e-Pub 2017. PMID: 28111717.
81. Baljevic M, Zaman S, Baladandayuthapani V, Lin YH, de Partovi CM, Berkova Z, Amini B, Thomas SK, Shah JJ, Weber DM, Fu M, Cleeland CS, Wang XS, Stellrecht CM, Davis RE, Gandhi V, Orlowski RZ. Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma. Ann Hematol 96(6):977-985, 2017. e-Pub 2017. PMID: 28337527.
82. Yue J, McKeever M, Sio TT, Xu T, Huo J, Shi Q, Nguyen QN, Komaki R, Gomez DR, Pan T, Wang XS, Liao Z. Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer. Clin Transl Radiat Oncol 4:1-7, 2017. e-Pub 2017. PMID: 29594201.
83. Murdock KW, Wang XS, Shi Q, Cleeland CS, Fagundes CP, Vernon SD. The utility of patient reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome. Qual Life Res 26(4):913-921, 2017. e-Pub 2017. PMID: 27600520.
84. Shi Q, Wang XS, Vaporciyan AA, Rice DC, Popat KU, Cleeland CS. Patient-reported symptom interference as a measure of postsurgery functional recovery in lung cancer. J Pain Symptom Manage 52(6):822-831, 2016. e-Pub 2016. PMID: 27521528.
85. Gomez DR, Blumenschein GR, Lee JJ, Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Gibbons DL, Karam JA, Kavanagh BD, Tang C, Komaki R, Louie AV, Palma DA, Tsao AS, Sepesi B, William WN, Zhang J, Shi Q, Wang XS, Swisher SG, Heymach JV. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol 17 (12)(12):1672-1682, 2016. e-Pub 2016. PMID: 27789196.
86. Shi Q, Mendoza TR, Wang XS, Cleeland CS. Using a symptom-specific instrument to measure patient-reported daily functioning in patients with cancer. Eur J Cancer 67:83-90, 2016. e-Pub 2016. PMID: 27620946.
87. Sio TT, Lin HK, Shi Q, Gunn GB, Cleeland CS, Lee JJ, Hernandez M, Blanchard P, Thaker NG, Phan J, Rosenthal DI, Garden AS, Morrison WH, Fuller CD, Mendoza TR, Mohan R, Wang XS, Frank SJ. Intensity modulated proton therapy versus intensity modulated photon radiation therapy for oropharyngeal cancer: first comparative results of patient-reported outcomes. Int J Radiat Oncol Biol Phys 95(4):1107-14, 2016. e-Pub 2016. PMID: 27354125.
88. Wang XS, Shi Q, Williams LA, Komaki R, Gomez DR, Lin SH, Chang JY, O'Reilly MS, Bokhari RH, Cox JD, Mohan R, Cleeland CS, Liao Z. Prospective study of patient-reported symptom burden in patients with non-small cell lung cancer undergoing proton or photon chemoradiation therapy. J Pain Symptom Manage 51(5):832-8, 2016. e-Pub 2016. PMID: 26891607.
89. Shah N, Shi Q, Williams LA, Mendoza TR, Wang XS, Reuben JM, Dougherty PM, Bashir Q, Qazilbash MH, Champlin RE, Cleeland CS, Giralt SA. Higher stem cell dose infusion after intensive chemotherapy does not improve symptom burden in older patients with multiple myeloma and amyloidosis. Biol Blood Marrow Transplant 22(2):226-31, 2016. e-Pub 2016. PMID: 26253006.
90. Wang XS, Shi Q, Dougherty PM, Eng C, Mendoza TR, Williams LA, Fogelman DR, Cleeland CS. Prechemotherapy touch-sensation deficits predict oxaliplatin-induced neuropathy in patients with colorectal cancer. Oncology 90(3):127-35, 2016. e-Pub 2016. PMID: 26882477.
91. Day RW, Cleeland CS, Wang XS, Fielder S, Calhoun J, Conrad C, Vauthey JN, Gottumukkala V, Aloia TA. Patient-reported outcomes accurately measure the value of an enhanced recovery program in liver surgery. J Am Coll Surg 221(6):1023-1030, 2015. e-Pub 2015.
92. Mendoza TR, Wang XS, Williams LA, Shi Q, Vichaya EG, Dougherty PM, Thomas SK, Yucel E, Bastida CC, Woodruff JF, Cleeland CS. Measuring therapy-induced peripheral neuropathy: preliminary development and validation of the Treatment-induced Neuropathy Assessment Scale (TNAS). J Pain 16(10):1032-43, 2015. e-Pub 2015. PMID: 26210041.
93. Fagundes CP, Shi Q, Vaporciyan AA, Rice DC, Popat KU, Cleeland CS, Wang XS. Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory. J Thorac Cardiovasc Surg 150(3):613-9.e2, 2015. e-Pub 2015. PMID: 26088408.
94. Wang XS, Shi Q, Williams LA, Shah ND, Mendoza TR, Cohen EN, Reuben JM, Cleeland CS, Orlowski RZ. Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma. Leuk Lymphoma 56(5):1-7, 2015. e-Pub 2015. PMID: 25248883.
95. Xu Y, Chen Y, Li P, Wang XS. Ren Shen Yangrong Tang for Fatigue in Cancer Survivors: A Phase I/II Open-Label Study. J Altern Complement Med 21(5):281-7, 2015. e-Pub 2015. PMID: 25918996.
96. Shi Q, Wang XS, Li G, Shah ND, Orlowski RZ, Williams LA, Mendoza TR, Cleeland CS. Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis. Cancer 121(7):1138-46, 2015. e-Pub 2015. PMID: 25469832.
97. Meyer LA, Nick AM, Shi Q, Wang XS, Williams L, Brock T, Iniesta MD, Rangel K, Lu KH, Ramirez PT. Perioperative trajectory of patient reported symptoms: A pilot study in gynecologic oncology patients. Gynecol Oncol 136(3):440-5, 2015. e-Pub 2015. PMID: 25647455.
98. Chu SH, Lee YJ, Lee ES, Geng Y, Wang XS, Cleeland CS. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review. Support Care Cancer 23(2):513-24, 2015. e-Pub 2015. PMID: 25256375.
99. Pan HY, Allen PK, Wang XS, Chang EL, Rhines LD, Tatsui CE, Amini B, Wang XA, Tannir NM, Brown PD, Ghia AJ. Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: secondary analysis of phase 1/2 trials. Int J Radiat Oncol Biol Phys 90(4):870-6, 2014. e-Pub 2014. PMID: 25227497.
100. de Carvalho Barbosa M, Kosturakis AK, Eng C, Wendelschafer-Crabb G, Kennedy WR, Simone DA, Wang XS, Cleeland CS, Dougherty PM. A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy. Cancer Res 74(21):5955-62, 2014. e-Pub 2014. PMID: 25183707.
101. Kosturakis AK, He Z, Li Y, Boyette-Davis JA, Shah N, Thomas SK, Zhang H, Vichaya EG, Wang XS, Wendelschafer-Crabb G, Kennedy WR, Simone DA, Cleeland CS, Dougherty PM. Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation density. J Clin Oncol 32(28):3156-62, 2014. e-Pub 2014. PMID: 25154818.
102. Sprangers MA, Thong MS, Bartels M, Barsevick A, Ordoñana J, Shi Q, Wang XS, Klepstad P, Wierenga EA, Singh JA, Sloan JA, Consortium G. Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update. Qual Life Res 23(7):1997-2013, 2014. e-Pub 2014. PMID: 24604075.
103. Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer 120(13):1975-84, 2014. e-Pub 2014. PMID: 24711162.
104. Wang XS, Shi Q, Shah ND, Heijnen CJ, Cohen EN, Reuben JM, Orlowski RZ, Qazilbash MH, Johnson VE, Williams LA, Mendoza TR, Cleeland CS. Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation. Clin Cancer Res 20(5):1366-74, 2014. e-Pub 2014. PMID: 24423611.
105. Jones D, Vichaya EG, Cleeland CS, Cohen L, Thekdi SM, Wang XS, Fisch MJ. Screening for depressed mood in patients with cancer using the MD Anderson Symptom Inventory: investigation of a practical approach for the oncologist. J Oncol Pract 10(2):e95-e102, 2014. e-Pub 2014. PMID: 24281151.
106. Fisch MJ, Zhao F, O'Mara AM, Wang XS, Cella D, Cleeland CS. Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors. Cancer 120(3):442-50, 2014. e-Pub 2014. PMID: 24151111.
107. Wang XS, Zhao F, Fisch MJ, O'Mara AM, Cella D, Mendoza TR, Cleeland CS. Prevalence and characteristics of moderate-to-severe fatigue: a multicenter study in cancer patients and survivors. Cancer 120(3):425-32, 2014. e-Pub 2014. PMID: 24436136.
108. Escalante CP, Meyers C, Reuben JM, Wang X, Qiao W, Manzullo E, Alvarez RH, Morrow PK, Gonzalez-Angulo AM, Wang XS, Mendoza T, Liu W, Holmes H, Hwang J, Pisters K, Overman M, Cleeland C. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J 20(1):8-14, 2014. e-Pub 2014. PMID: 24445757.
109. Jones D, Vichaya EG, Wang XS, Sailors MH, Cleeland CS, Wefel JS. Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. Cancer 119(23):4188-95, 2013. e-Pub 2013. PMID: 24105672.
110. Shi Q, Mendoza TR, Gunn GB, Wang XS, Rosenthal DI, Cleeland CS. Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res 22(9):2331-9, 2013. e-Pub 2013. PMID: 23475689.
111. Barney BJ, Wang XS, Lu C, Liao Z, Johnson VE, Cleeland CS, Mendoza TR. Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer. Qual Life Res 22(8):2143-50, 2013. e-Pub 2013. PMID: 23371797.
112. Vichaya EG, Wang XS, Boyette-Davis JA, Mendoza TR, He Z, Thomas SK, Shah N, Williams LA, Cleeland CS, Dougherty PM. Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy. Cancer Chemother Pharmacol 71(6):1531-40, 2013. e-Pub 2013. PMID: 23543296.
113. Thong MS, Mols F, Wang XS, Lemmens VE, Smilde TJ, van de Poll-Franse LV. Quantifying fatigue in (long-term) colorectal cancer survivors: a study from the population-based patient reported outcomes following initial treatment and long term evaluation of survivorship registry. Eur J Cancer 49(8):1957-66, 2013. e-Pub 2013. PMID: 23453750.
114. Cleeland CS, Sloan JA, Cella D, Chen C, Dueck AC, Janjan NA, Liepa AM, Mallick R, O'Mara A, Pearson JD, Torigoe Y, Wang XS, Williams LA, Woodruff JF, Task Force C(TSOCUPOM. Recommendations for including multiple symptoms as endpoints in cancer clinical trials : A report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force. Cancer 119(2):411-20, 2013. e-Pub 2013. PMID: 22930243.
115. Jones D, Vichaya EG, Wang XS, Williams LA, Shah ND, Thomas SK, Johnson VE, Champlin RE, Cleeland CS, Mendoza TR. Validation of the M. D. Anderson Symptom Inventory multiple myeloma module. J Hematol Oncol 6(1):13, 2013. e-Pub 2013. PMID: 23384030.
116. Garg AK, Shiu AS, Yang J, Wang XS, Allen P, Brown BW, Grossman P, Frija EK, McAleer MF, Azeem S, Brown PD, Rhines LD, Chang EL. Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer 118(20):5069-77, 2012. e-Pub 2012. PMID: 22511344.
117. Wang XS, Williams LA, Krishnan S, Liao Z, Liu P, Mao L, Shi Q, Mobley GM, Woodruff JF, Cleeland CS. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun 26(5):699-705, 2012. e-Pub 2012. PMID: 22251605.
118. Boyette-Davis JA, Eng C, Wang XS, Cleeland CS, Wendelschafer-Crabb G, Kennedy WR, Simone DA, Zhang H, Dougherty PM. Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy. Clin Cancer Res 18(11):3180-3187, 2012. e-Pub 2012. PMID: 22496202.
119. Wang XS, Rhines LD, Shiu AS, Yang JN, Selek U, Gning I, Liu P, Allen PK, Azeem SS, Brown PD, Sharp HJ, Weksberg DC, Cleeland CS, Chang EL. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol 13(4):395-402, 2012. e-Pub 2012. PMID: 22285199.
120. Garg AK, Wang XS, Shiu AS, Allen P, Yang J, McAleer MF, Azeem S, Rhines LD, Chang EL. Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: The University of Texas MD Anderson Cancer Center Experience. Cancer 117(15):3509-16, 2011. e-Pub 2011. PMID: 21319143.
121. Cleeland CS, Mendoza TR, Wang XS, Woodruff JF, Palos GR, Richman SP, Nazario A, Lynch GR, Liao KP, Mobley GM, Lu C. Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center. J Clin Oncol 29(21):2859-65, 2011. e-Pub 2011. PMID: 21690477.
122. Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, Malveaux D, Shah PK, Gning I, Hofstetter WL, Putnam JB, Vaporciyan AA. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol 29(8):994-1000, 2011. e-Pub 2011. PMID: 21282546.
123. Mendoza TR, Wang XS, Lu C, Palos GR, Liao Z, Mobley GM, Kapoor S, Cleeland CS. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist 16(2):217-27, 2011. e-Pub 2011. PMID: 21285393.
124. Shi Q, Trask PC, Wang XS, Mendoza TR, Apraku WA, Malekifar M, Cleeland CS. Does recall period have an effect on cancer patients' ratings of the severity of multiple symptoms?. J Pain Symptom Manage 40(2):191-9, 2010. e-Pub 2010. PMID: 20579835.
125. Wang XS, Shi Q, Williams LA, Mao L, Cleeland CS, Komaki RR, Mobley GM, Liao Z. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun 24(6):968-74, 2010. e-Pub 2010. PMID: 20353817.
126. Nejmi M, Wang XS, Mendoza TR, Gning I, Cleeland CS. Validation and application of the Arabic version of the M. D. Anderson Symptom Inventory in Moroccan patients with cancer. J Pain Symptom Manage 40(1):75-86, 2010. e-Pub 2010. PMID: 20619213.
127. Wang XS, Cleeland CS, Mendoza TR, Yun YH, Wang Y, Okuyama T, Johnson VE. Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst 102(10):732-738, 2010. e-Pub 2010. PMID: 20348233.
128. Wang XS, Williams LA, Eng C, Mendoza TR, Shah NA, Kirkendoll KJ, Shah PK, Trask PC, Palos GR, Cleeland CS. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer 116(8):2053-63, 2010. e-Pub 2010. PMID: 20166216.
129. Nguyen QN, Shiu AS, Rhines LD, Wang H, Allen PK, Wang XS, Chang EL. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(4):1185-92, 2010. e-Pub 2010. PMID: 19632064.
130. Wang XS, Shi Q, Lu C, Basch EM, Johnson VE, Mendoza TR, Mobley GM, Cleeland CS. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced non-small cell lung cancer. Cancer 116(1):137-45, 2010. e-Pub 2010. PMID: 19852033.
131. Mendoza TR, Laudico AV, Wang XS, Guo H, Matsuda ML, Yosuico VD, Fragante EP, Cleeland CS. Assessment of fatigue in cancer patients and community dwellers: validation study of the Filipino version of the Brief Fatigue Inventory. Oncology 79(1-2):112-7, 2010. e-Pub 2010. PMID: 21088437.
132. Park HC, Janjan NA, Mendoza TR, Lin EH, Vadhan-Raj S, Hundal M, Zhang Y, Delclos ME, Crane CH, Das P, Wang XS, Cleeland CS, Krishnan S. Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 75(3):775-81, 2009. e-Pub 2009. PMID: 19231100.
133. Yuan X, Liao Z, Liu Z, Wang LE, Tucker SL, Mao L, Wang XS, Martel M, Komaki R, Cox JD, Milas L, Wei Q. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 27(20):3370-8, 2009. e-Pub 2009. PMID: 19380441.
134. Shi Q, Wang XS, Mendoza TR, Pandya KJ, Cleeland CS. Assessing persistent cancer pain: a comparison of current-pain ratings and pain recalled from the past week. J Pain Symptom Manage 37(2):168-74, 2009. e-Pub 2009. PMID: 18676116.
135. Rosenthal DI, Mendoza TR, Chambers MS, Burkett VS, Garden AS, Hessell AC, Lewin JS, Ang KK, Kies MS, Gning I, Wang XS, Cleeland CS. The M. D. Anderson Symptom Inventory-Head and Neck Module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys 72(5):1355-61, 2008. e-Pub 2008. PMID: 18501527.
136. Wang XS, Shi Q, Williams LA, Cleeland CS, Mobley GM, Reuben JM, Lee BN, Giralt SA. Serum IL-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer 113(8):2102-9, 2008. e-Pub 2008. PMID: 18792065.
137. Escalante CP, Manzullo EF, Lam TP, Ensor JE, Valdres RU, Wang XS. Fatigue and its risk factors in cancer patients who seek emergency care. J Pain Symptom Manage 36(4):396-412, 2008. e-Pub 2008. PMID: 18411011.
138. Yun YH, Lee MK, Chun HN, Lee YM, Park SM, Mendoza TR, Wang XS, Cleeland CS. Fatigue in the general Korean population: application and normative data of the Brief Fatigue Inventory. J Pain Symptom Manage 36(3):259-67, 2008. e-Pub 2008. PMID: 18411013.
139. Tseng TH, Cleeland CS, Wang XS, Lin CC. Assessing cancer symptoms in adolescents with cancer using the Taiwanese version of the M. D. Anderson Symptom Inventory. Cancer Nurs 31(3):E9-E16, 2008. e-Pub 2008. PMID: 18453871.
140. Kalyadina SA, Ionova TI, Ivanova MO, Uspenskaya OS, Kishtovich AV, Mendoza TR, Guo H, Novik A, Cleeland CS, Wang XS. Russian Brief Pain Inventory: validation and application in cancer pain. J Pain Symptom Manage 35(1):95-102, 2008. e-Pub 2008. PMID: 17980999.
141. Zhao Y, Wang XS, Li PP. Investigation of common symptoms of cancer and reliability analysis. Chin J Integr Med 13(3):195-9, 2007. e-Pub 2007. PMID: 17898950.
142. Chang EL, Shiu AS, Mendel E, Mathews LA, Mahajan A, Allen PK, Weinberg JS, Brown BW, Wang XS, Woo SY, Cleeland C, Maor MH, Rhines LD. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7(2):151-60, 2007. e-Pub 2007. PMID: 17688054.
143. Chang YJ, Lee JS, Lee CG, Lee WS, Lee KS, Bang SM, Wang XS, Mendoza TR, Cleeland CS, Yun YH. Assessment of clinical relevant fatigue level in cancer. Support Care Cancer 15(7):891-6, 2007. e-Pub 2007. PMID: 17318593.
144. Anderson KO, Giralt SA, Mendoza TR, Brown JO, Neumann JL, Mobley GM, Wang XS, Cleeland CS. Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplant 39(12):759-66, 2007. e-Pub 2007. PMID: 17438588.
145. Jeon YS, Kim HK, Cleeland CS, Wang XS. Clinicians' practice and attitudes toward cancer pain management in Korea. Support Care Cancer 15(5):463-9, 2007. e-Pub 2007. PMID: 17115200.
146. Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, Weber RS, Lewin JS, Garden AS, Ang KK, Wang XS, Cleeland CS. Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson Symptom Inventory, head and neck module. Head Neck 29(10):923-31, 2007. e-Pub 2007. PMID: 17358040.
147. Kwon YC, Yun YH, Lee KH, Son KY, Park SM, Chang YJ, Wang XS, Mendoza TR, Cleeland CS. Symptoms in the lives of terminal cancer patients: which is the most important?. Oncology 71(1-2):69-76, 2007. e-Pub 2007. PMID: 17344672.
148. Lin CC, Chang AP, Cleeland CS, Mendoza TR, Wang XS. Taiwanese version of the M. D. Anderson Symptom Inventory: symptom assessment in cancer patients. J Pain Symptom Manage 33(2):180-8, 2007. e-Pub 2007. PMID: 17280923.
149. Shih YC, Wang XS, Cantor SB, Cleeland CS. The association between symptom burdens and utility in Chinese cancer patients. Qual Life Res 15(8):1427-38, 2006. e-Pub 2006. PMID: 16791743.
150. Wang XS, Fairclough DL, Liao Z, Komaki R, Chang JY, Mobley GM, Cleeland CS. Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol 24(27):4485-91, 2006. e-Pub 2006. PMID: 16983118.
151. Lin CC, Chang AP, Chen ML, Cleeland CS, Wang XS. Validation of the Taiwanese version of the Brief Fatigue Inventory. J Pain Symptom Manage 32(1):52-9, 2006. e-Pub 2006. PMID: 16824985.
152. Wang XS, Laudico AV, Guo H, Mendoza TR, Matsuda ML, Yosuico VD, Fragante EP, Cleeland CS. Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients. J Pain Symptom Manage 31(6):542-52, 2006. e-Pub 2006. PMID: 16793494.
153. Yun YH, Mendoza TR, Kang IO, You CH, Roh JW, Lee CG, Lee WS, Lee KS, Bang SM, Park SM, Cleeland CS, Wang XS. Validation study of the Korean version of the M. D. Anderson Symptom Inventory. J Pain Symptom Manage 31(4):345-52, 2006. e-Pub 2006. PMID: 16632082.
154. Nejmi M, Wang XS, Mendoza TR, Gning I, Cleeland CS. Preliminary validation of the Arabic version of the Brief Pain Inventory (BPI-A) for cancer pain patients (Étude préliminaire de validation de la version arabedu questionnaire "Brief Pain Inventory"dans ladouleur cancéreuse) [in French]. Le Courrier de l'Algologie 5(1):27-35, 2006. e-Pub 2006.
155. Ivanova MO, Ionova TI, Kalyadina SA, Uspenskaya OS, Kishtovich AV, Guo H, Mendoza TR, Novik A, Cleeland CS, Wang XS. Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory. J Pain Symptom Manage 30(5)(5):443-53, 2005. e-Pub 2005. PMID: 16310618.
156. Yun YH, Wang XS, Lee JS, Roh JW, Lee CG, Lee WS, Lee KS, Bang SM, Mendoza TR, Cleeland CS. Validation study of the Korean version of the Brief Fatigue Inventory. J Pain Symptom Manage 29(2):165-72, 2005. e-Pub 2005. PMID: 15733808.
157. Wang XS, Wang Y, Guo H, Mendoza TR, Hao XS, Cleeland CS. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer 101(8):1890-901, 2004. e-Pub 2004. PMID: 15386315.
158. Wang XS, Hao XS, Wang Y, Guo H, Jiang YQ, Mendoza TR, Cleeland CS. Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C). J Pain Symptom Manage 27(4):322-32, 2004. e-Pub 2004. PMID: 15050660.
159. Wang XS, Di LJ, Reyes-Gibby CC, Guo H, Liu SJ, Cleeland CS. End-of-life care in urban areas of China: a survey of 60 oncology clinicians. J Pain Symptom Manage 27(2):125-32, 2004. e-Pub 2004. PMID: 15157036.
160. Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y. Adequacy of cancer pain management in a Japanese cancer hospital. Jpn J Clin Oncol 34(1):37-42, 2004. e-Pub 2004. PMID: 15020661.
161. Yun YH, Mendoza TR, Heo DS, Yoo T, Heo BY, Park HA, Shin HC, Wang XS, Cleeland CS. Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the Brief Pain Inventory. Oncology 66(6):439-44, 2004. e-Pub 2004. PMID: 15452372.
162. Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y. Japanese version of the M. D. Anderson Symptom Inventory: a validation study. J Pain Symptom Manage 26(6):1093-104, 2003. e-Pub 2003. PMID: 14654261.
163. Lee JQ, Simmonds MJ, Wang XS, Novy DM. Differences in physical performance between men and women with and without lymphoma. Arch Phys Med Rehabil 84(12):1747-52, 2003. e-Pub 2003. PMID: 14669178.
164. Reyes-Gibby CC, Mendoza TR, Wang XS, Anderson KO, Cleeland CS. Pain and fatigue in community-dwelling adults. Pain Med 4(3):231-7, 2003. e-Pub 2003.
165. Wang XS, Tang JY, Zhao M, Guo H, Mendoza T, Cleeland CS. Pediatric cancer pain management practices and attitudes in China. J Pain Symptom Manage 26(2):748-59, 2003. e-Pub 2003. PMID: 12906960.
166. Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA, Miller AH, Payne R, Reuben JM, Wang XS, Lee BN. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97(11):2919-25, 2003. e-Pub 2003. PMID: 12767108.
167. Anderson KO, Getto CJ, Mendoza TR, Palmer SN, Wang XS, Reyes-Gibby CC, Cleeland CS. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage 25(4):307-18, 2003. e-Pub 2003. PMID: 12691682.
168. Okuyama T, Wang XS, Akechi T, Mendoza T, Hosaka T, Cleeland CS, Uchitomi Y. The validation study of the Japanese version of the Brief Fatigue Inventory. J Pain Symptom Manage 25(2):106-17, 2003. e-Pub 2003.
169. Wang XS, Li TD, Yu SY, Gu WP, Xu GW. China: status of pain and palliative care. J Pain Symptom Manage 24(2):177-9, 2002. e-Pub 2002.
170. Wang XS, Giralt SA, Mendoza TR, Engstrom MC, Johnson BA, Peterson N, Broemeling LD, Cleeland CS. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol 20(5):1319-28, 2002. e-Pub 2002. PMID: 11870175.
171. Wang XS, Janjan NA, Guo H, Johnson BA, Engstrom MC, Crane CH, Mendoza TR, Cleeland CS. Fatigue during preoperative chemoradiation for resectable rectal cancer. Cancer 92(6 Suppl):1725-32, 2001. e-Pub 2001. PMID: 11598894.
172. Yu S, Wang XS, Cheng Y, Yang J, Cleeland CS. Special aspects of cancer pain management in a Chinese general hospital. Eur J Pain 5(Suppl A):15-20, 2001. e-Pub 2001. PMID: 11798212.
173. Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC. Assessing symptom distress in cancer patients: the M. D. Anderson Symptom Inventory. Cancer 89(7):1634-46, 2000. e-Pub 2000. PMID: 11013380.
174. Wang XS, Cleeland CS, Mendoza TR, Engstrom MC, Liu S, Xu G, Hao X, Wang Y, Ren XS. The effects of pain severity on health-related quality of life: a study of Chinese cancer patients. Cancer 86(9):1848-55, 1999. e-Pub 1999. PMID: 10547560.
175. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85(5):1186-96, 1999. e-Pub 1999. PMID: 10091805.
176. Cleeland CS, Wang XS. Measuring and understanding fatigue. Oncology 13(11A):91-97, 1999. e-Pub 1999.
177. Wang XS, Mendoza TR, Gao SZ, Cleeland CS. The Chinese version of the Brief Pain Inventory (BPI-C): its development and use in a study of cancer pain. Pain 67(2):407-16, 1996. e-Pub 1996. PMID: 8951936.
178. Liu S, Wang XS, Wan FL. Peripheral blood T-cell changes in 50 patients with multiple myeloma. Chinese Journal of Immunology 10(3):145, 1994. e-Pub 1994.
179. Liu S, Zhang XQ, Zhao YL, Wang XS, Wan FL. Effect of Qi-reinforcing and kidney-tonifing decoction on T-cell of patients with multiple myeloma. Chinese Journal of Integrated Traditional and Western Medicine 13(11):651, 1993. e-Pub 1993.
180. Gao SZ, Sun RZ, Wang XS, Xu JZ, Cleeland CS. A survey of 215 cases of cancer patients with pain in the Beijing area. Beijing Medical Journal 14(5):381, 1992. e-Pub 1992.
181. Liu S, Wang XS, Zhao Y, Wan FL. Evaluation of bone lesions in patients with multiple myeloma. Chinese Journal of Hematology 13(7):352-4, 1992. e-Pub 1992.
182. Liu S, Zhao Y, Wang XS. Four cases of solitary plasmocytoma of bone. National Medical Journal of China 70(3):178, 1990. e-Pub 1990.

Invited Articles

1. Wang XS. Pathophysiology of cancer-related fatigue. Clin J Oncol Nurs 12(5 Suppl):11-20, 2008. e-Pub 2008. PMID: 18842520.
2. Wang XS, Cleeland CS. Symptoms that cluster around cancer pain: a research agenda. Pain: Clinical Updates XIV:1-4, 2006. e-Pub 2006.
3. Wang XS. Measurement of cancer-related fatigue. Anemia and Quality of Life in Oncology 4:5-8, 2001. e-Pub 2001.
4. Wang XS, Gottumukkala V. Patient-Reported Outcomes: Is this the Missing Link in Patient-Centered Perioperative Care?. Best Practice & Research Clinical Anaesthesiology.

Review Articles

1. Amdal, CD, Sørum, R, Alanya, A, Schlichting, M, Roychoudhury, S, Bhatnagar, V, Wintner, LM, Regnault, A, Ingelgård, A, Coens, C, Le Cessie, S, Holzner, B, Chang, J, Taphoorn, MJ, Cislo, P, Giesinger, JM, Cappelleri, JC, Pawar, V, ten Seldam, S, Papadopoulos, E, Calvert, M, Joseph, KL, Bottomley, A, Griebsch, I, Arraras, JI, Astrup, GL, Basch, EM, Belančić, A, Brundage, MD, Campbell, A, Rerhou Rantell, K, Cocks, K, Cherny, NI, Eremenco, S, Ferrer, M, Fiero, MH, Gerlinger, C, Goetghebeur, E, Grouven, U, Lauer, A, Aiyegbusi, OL, Machingura, A, Mizusawa, J, Molenberghs, G, Aa Petersen, M, Reijneveld, JC, Ringash, J, Rumpold, G, Rutherford, C, Quinten, C, Sail, K, Sasseville, M, Sauerbrei, W, Schiel, A, Smith, AW, Snyder, CF, Velikova, G, Wang, XS, Bjordal, K, Pe, M, Alexi, S, Al-naesan, I, Black, J, Boele, F, Bogaerts, K, Böhme, S, Chen, TY, Chiavaro, F, Claus, V, Cleeland, C, Coon, C, Cruz Rivera, S, Dekanic Arbanas, G, Desplanques, G, Emechebe, N, Fitzgerald, K, Garin, O, Ge, M, Gilbert, A, Groenvold, M, Gross, F, Horodniceanu, E, Johnson, LL, Joyner, K, Kamalakar, R, King, M, Kluetz, PG, Kuljanic-Vlasic, K, Latino, N, Liu, L, Maguri, M, Martinelli, F, Mazerolle, F, Mitchell, SA, Morgan, KE, Musoro, J, Ness, D, Nsiah, I, Oosting, S, Peacock, R. SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials. The Lancet Oncology 26(12):e683-e693, 2025. e-Pub 2025. PMID: 41308689.
2. Wang, XS, Srour, S. Patient-reported outcomes after CAR T-cell therapy in patients with hematological malignancies. Hematology (United States) 2024(1):102-108, 2024. e-Pub 2024. PMID: 39644035.
3. Lai, H, Yang, P, Wang, XS, Lim, D, Lam, A, Shi, Y, Huang, Y, Zhu, X. Are Published Cancer Care Trial Protocols With Traditional Chinese Medicine Interventions Concordant With SPIRIT-TCM Extension 2018? A Scoping Review on Published Trial Protocols Between 2019 and 2022. Integrative cancer therapies 23, 2024. e-Pub 2024. PMID: 38291957.
4. Han, B, Liu, YJ, Jin, J, Xu, HK, Zhang, W, Ren, S, Wang, XS, Liu, J. Symptom assessment and management in patients with lung cancer undergoing conventional or traditional chinese medicine care. World Journal of Traditional Chinese Medicine 9(3):235-242, 2023. e-Pub 2023.
5. Pe, M, Alanya, A, Sørum, R, Amdal, CD, Bjordal, K, Chang, J, Cislo, P, Coens, C, Dirven, L, Speck, RM, Fitzgerald, K, Galinsky, J, Giesinger, JM, Holzner, B, Le Cessie, S, O'Connor, D, Oliver, K, Pawar, V, Quinten, C, Schlichting, M, Ren, J, Roychoudhury, S, Taphoorn, MJ, Velikova, G, Wintner, LM, Griebsch, I, Bottomley, A, Bui, CN, Emechebe, N, Kamalakar, R, Papadopoulos, E, Sail, K, Sen, R, Turner, SC, Cocks, K, Reijneveld, JC, Gerlinger, C, Keating, KN, Su, Y, Wolf, B, Ge, M, Ingelgaard, A, Peil, B, Voorhaar, M, Wong, B, Dekanic Arbanas, G, Kuljanic-Vlasic, K, Petranovic, D, Cleeland, C, Wang, XS. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI). The lancet oncology 24(6):e270-e283, 2023. e-Pub 2023. PMID: 37269858.
6. Gentile D, Beeler D, Wang XS, Ben-Arye E, Zick SM, Bao T, Carlson LE, Ghelman R, Master V, Tripathy D, Zhi WI. Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research Recommendations. Oncology (Williston Park) 36(5):276-287, 2022. e-Pub 2022. PMID: 35576178.
7. Wang, XS, Gottumukkala, V. Patient-reported outcomes. Best Practice and Research: Clinical Anaesthesiology 35(4):565-573, 2021. e-Pub 2021. PMID: 34801218.
8. Wang, XS, Cleeland, C. CANCER-RELATED FATIGUE. Journal of Cancer Rehabilitation 4:308-312, 2021. e-Pub 2021.
9. Wang XS, Woodruff JF. Cancer-related and treatment-related fatigue. Gynecol Oncol 136(3):446-52, 2015. e-Pub 2015. PMID: 25458588.
10. Claassens L, van Meerbeeck J, Coens C, Quinten C, Ghislain I, Sloan EK, Wang XS, Velikova G, Bottomley A. Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials. J Clin Oncol 29(15):2104-20, 2011. e-Pub 2011. PMID: 21464420.
11. Lee BN, Dantzer R, Langley KE, Bennett GJ, Dougherty PM, Dunn AJ, Meyers CA, Miller AH, Payne R, Reuben JM, Wang XS, Cleeland CS. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11(5):279-92, 2004. e-Pub 2004. PMID: 15316238.

Professional Educational Materials

1. Ren XS, Wang XS, Liu S, Hao X. Psychometric and clinical evaluation of the Chinese version of the SF-36 health survey among cancer patients in China, 2003.

Editorials

1. Wang XS, Giordano S. Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors: Andrykowski MA, Donovan KA, Laronga C, et al (Univ of Kentucky, Lexington; Moffitt Cancer Ctr, Tampa, FL) Cancer 116:5740-5748, 2010. Breast Diseases Quarterly 22(3):257-8, 2011.

Abstracts

1. Wang XS, Moreno AC, Shen S, Kamal M, Herrera M, Hutcheson K. Defining Critical Patient-reported Outcomes to Build ePRO-based Pathway for Patient Care After Radiation for Head and Neck Cancer. Qol Res, 2023. e-Pub 2023.
2. Wang XS, Hess LM, Shen S, Gonzalez E, Kamal M, Liepa AM. Symptom Burden and Functioning Status in Patients with Advanced Upper Gastrointestinal Cancers, 2022. e-Pub 2022.
3. Wang XS, Srour SA, Kamal M, Ahmed S, Whisenant M, Subbiah IM, Sh-E S, Mendoza T, Cleeland CS, Kebriaei P, Neelapu SS, Rezvani K, Shpall E. Validating a patient-reported outcome measure MDASI-CAR for patient care after Chimeric antigen receptor T-cell therapy for hematological malignancies. QoL Research, 2022. e-Pub 2022.
4. Kamal M, Wang XS, Ramirez PT, Iniesta MD, Cleeland CS, Meyer LA. Patient-reported outcomes at discharge determine the risk of developing postoperative complications after surgery for gynecologic tumors. QoL REs, 2022. e-Pub 2022.
5. Meyer L, Iniesta MD, Munsell MF, Basabe S, Suki T, Lasala J, Mena G, Shafer A, Jazaeri A, Wang S, Cohen L, Ramirez PT. Integration of Self-Hypnosis in an Enhanced Recovery After Surgery Program: A Prospective Randomized Trial, 2022. e-Pub 2022.
6. Wang XS, Kamal M, Xu J, Chen J, Gottumukkala V, Garcia-Gonzalez A, Cleeland CS, Aloia TA. Patient-reported outcomes (PRO) predict the risk of delayed readiness to return to intended oncologic therapy (RIOT) after oncologic hepatic resection: value of implementing PROs in postoperative care. QoL Res, 2021. e-Pub 2021.
7. Kamal M, Wang XS, Chen TH, Lin F, Garcia-Gonzalez A, Cleeland C, Navai N. Utilizing patient-reported outcomes at discharge to determine the symptom and physical recovery time after oncologic surgery for bladder carcinoma. QoL Res, 2021. e-Pub 2021.
8. Wang XS. Patient-Reported Symptom Burden and Functioning in Patients with Advanced Esophageal, Gastroesophageal Junction (GEJ), and Gastric Cancer Undergoing Chemotherapy. Journal of Clinical Oncology 39(3-suppl):183, 2021. e-Pub 2021.
9. Wang XS, Srour S, Subbiah I, Whisenant M, Williams L, Chen TH, Ponce D, Garcia Gonzalez A, Jamal M, Ahmed S, Kebriaei P, Neelapu S, Shpall E. Patient-Reported Symptoms Burden after CAR T-cell Therapy for Relapsed/Refractory Lyphoma. International Society for Quality of Life Research (ISOQOL) Annual Conference, 2020. e-Pub 2020.
10. Whisenant, Srour S, Subbiah I, Griffin D, Williams L, Wang XS. The Unique Symptom Burden of Receiving CAR T-cell Therapy, 2020. e-Pub 2020.
11. Shi Q, Meyer L, Dai W, Xu W, Nie Y, Cleeland C, Wang XS. Identifying Difficulties and Most-interested Findings for Analyzing Patient-Reported Outcome Data from Perioperative Settings, 2020. e-Pub 2020.
12. Jomaa M, Wang XS, Shi Q, Williams L, Chen T, Garcia Gonzalez A, Navai N. Validation and Application of M. D. Anderson Symptom Inventory Module for Measuring Multiple Symptoms in Patients with Bladder Cancer (MDASI-BLC) for Perioperative Care, 2019. e-Pub 2019.
13. Cleeland C, Shi Q, Meyer L, Chen T, Garcia-Gonzalez A, Iniesta-Donate M, Chen T, Griffin D, Wang XS. Recovery of symptom burden and functioning for patients with late discharge after an open surgery for GYN tumors. Clinical Oncology, 2019. e-Pub 2019.
14. Wang XS, Shi Q, Cleeland C, Chen T, Garcia-Gonzalez A, Iniesta-Donate M, Chen T, Griffin D, Meyer L. Patient-reported outcomes during hospitalization for patients with late discharge after an open surgery for GYN tumors. Clinical Oncology, 2019. e-Pub 2019.
15. Wang XS, Shi Q, Chen T, Cleeland C, Garcia Gonzalez A, Ramirez P, Iniesta-Donate M, Meyer L. Measuring Functional Impairment Status with Objective and Subjective Methods for Perioperative Care Post Gyn Surgery, 2019. e-Pub 2019.
16. Wang XS, Shi Q, Xue D, Cleeland C, Chen T, Li P. Measuring Symptom Burden in Geriatric Oncology with MD Anderson Symptom Inventory (MDASI) in Chinese Cancer Patients and Survivors. MDASI Application in Geriatric Oncology, 2019. e-Pub 2019.
17. Raghav K, Wang XS, Xiao L, Dasari A, Morris II V, Johnson B, Shen JP, Parseghian C, Kee B, Shureiqi I, Fogelman D, Wolff R, Raymond V, Odegaard J, Lanman R, Overman M, Kopetz S. A Randomized Study Evaluating Tailoring of Advanced/Metastatic Colorectal Cancer (mCRC) Therapy using Circulating Cell-free Tumor DNA (ctDNA) (TACT-D), 2019. e-Pub 2019.
18. Wang XS, Shi Q, Xue D, Cleeland C, Chen T, Li P. Establishing a Screening Tool for Measuring Poor Performance Status Using Patient Reported Outcomes in Geriatric Oncology. Define Poor PS by PROs in Geriatric Oncology, 2019. e-Pub 2019.
19. Wang XS, Shi Q, Chen T, Cleeland C, Garcia Gonzalez A, Ramirez P, Maria I, Meyer L. Measuring Functioning Impairment Status with Objective and Subjective Methods for Perioperative Care Post GYN Surgery, 2019. e-Pub 2019.
20. Wang XS, MD, MPH, Shi Q, PhD, Chen TT, MS, Gonzalez AG, PhD, Cleeland C, PhD. Phase II Randomized Study: Effectiveness of Symptom Reduction by Minocycline in Patients with Multiple Myeloma, 2018. e-Pub 2018.
21. Wang XS, Shi Q, Xu Y, Chen TH, Li P. Fatigue reduction by Renshen Yangrong Tang (RSYRT) in patients with cancer: A randomized, double-blind, active-agent controlled clinical trial. Qual Life Res 27:S108, 2018. e-Pub 2018.
22. Wang XS, Shi Q, Bhadkamkar N, Heijnen C, Cleeland CS, Eng C. Effect of minocycline on symptom burden and inflammation markers in patients with colorectal cancer: A randomized phase II trial [abstract]. American Society of Clinical Oncology (ASCO) 54th Annual Meeting, Chicago IL, Jun 1-5, 2018. J Clin Oncol 36(Suppl), 2018. e-Pub 2018.
23. George G, Mendoza TR, Iwuanyanwu EC, Shi Q, Piha-Paul SA, Williams LA, Karp DD, Naing A, Janku F, Bokhari RH, Wang XS, Hong DS, Cleeland CS. Longitudinal patient-reported symptom severity and symptom interference with activity-related and mood-related functioning and survival in patients with advanced cancer on early-phase clinical trials of immunotherapeutic or targeted agents [abstract]. American Society of Clinical Oncology (ASCO) 54th Annual Meeting, Chicago IL, Jun 1-5, 2018. J Clin Oncol 36(Suppl), 2018. e-Pub 2018.
24. Wang XS, Shi Q, Williams LA, Cleeland CS, Garcia-Gonzalez A, Ramirez PT, Iniesta MD, Siverand A, Meyer LA. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring symptom burden in patients with gynecologic cancer (MDASI-Peri-GYN) for perioperative care [abstract]. Enhanced Recovery After Surgery (ERAS) 6th World Congress, Stockholm, Sweden, May 23-25, 2018, 2018. e-Pub 2018.
25. Meyer LA, Lasala J, Iniesta MD, Shi Q, Cain KE, Corzo C, Earles T, Harris M, Wang XS, Ramirez PT. Adoption of an enhanced recovery program leads to decreased opioid use and associated patient-reported opioid-related adverse symptoms [abstract]. Enhanced Recovery After Surgery (ERAS) 6th World Congress, Stockholm, Sweden, May 23-25, 2018, 2018. e-Pub 2018.
26. Wang XS, Shi Q, Bhadkamkar N, Eng C, Cleeland CS. Discrepancy of symptom burden during standard chemotherapy for patients with colorectal cancer between public hospital and tertiary cancer center [abstract]. Innovative Molecular Analysis Technologies (IMAT) 18th Annual Principal Investigators Meeting, Rockville MD, Dec 6-8, 2017, 2017. e-Pub 2017.
27. Xu Y, Li PP, Shi Q, Wang XS. A randomized, double blind, active agent controlled clinical trial for fatigue reduction by Renshen Yangrong Tang (RSYRT) in patients with cancer [abstract]. Society for Integrative Oncology (SIO) 17th Annual International Conference, Chicago IL, Nov 12-14, 2017, 2017. e-Pub 2017.
28. Shi Q, Wang XS, Williams LA, Mendoza TR, Simon G, Cleeland C. Symptom trajectories during chemotherapy predict overall survival in patients with advanced non-small cell lung cancer [abstract]. International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer, Yokohama, Japan, Oct 15-18, 2017. J Thorac Oncol 12(11 Supplement 2):S2083, 2017. e-Pub 2017.
29. Wang XS, Shi Q, Liao Z, Simon G, Cleeland C. Tracking major symptom burden from chemotherapy concurrent with 3D vs. IMRT vs. proton beam radiotherapy for NSCLC [abstract]. International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer, Yokohama, Japan, Oct 15-18, 2017. J Thorac Oncol 12(11 Supplement 2):S1745-6, 2017. e-Pub 2017.
30. Chen TY, Shi Q, Chan W, Wang XS, Mendoza T, Cleeland CS. The prognostic value of cancer-related fatigue on overall survival in patients with advanced NSCLC: application of Continuous Time Markov Chains on symptom research [abstract]. International Society for Quality of Life Research (ISOQOL) 24th Annual Conference, Philadelphia PA, Oct 18-21, 2017. Qual Life Res 26(1 Supplement):34, 2017. e-Pub 2017.
31. Williams LA, Mendoza T, Shi Q, Wang XS, Bamidele O, Cleeland CS. Qualitative methods of patient-reported outcome measure development [abstract]. International Society for Quality of Life Research (ISOQOL) 24th Annual Conference, Philadelphia PA, Oct 18-21, 2017. Qual Life Res 26(1 Supplement):84-5, 2017. e-Pub 2017.
32. Wang XS, Shi Q, Shelton V, Massey RL. Benefits of an enhanced recovery program after surgery for gastrointestinal cancer: clinical and patient perspectives [abstract]. International Society for Quality of Life Research (ISOQOL) 24th Annual Conference, Philadelphia PA, Oct 18-21, 2017. Qual Life Res 26(1 Supplement):134, 2017. e-Pub 2017.
33. Shi Q, Gunn B, Wang XS, Mendoza T, Rosenthal D, Cleeland CS. Using patient-reported functional impairment to quantify tolerability of radiotherapy in patients with head and neck cancer [abstract]. International Society for Quality of Life Research (ISOQOL) 24th Annual Conference, Philadelphia PA, Oct 18-21, 2017. Qual Life Res 26(1 Supplement):45, 2017. e-Pub 2017.
34. George GC, Mendoza T, Iwuanyanwu E, Anderson K, Piha-Paul S, Naing A, Wang XS, Hong DS, Cleeland CS. Patient-reported symptom interference with activity-related and mood-related functioning in patients with advanced cancer in a Phase I clinical trials clinic. [abstract]. International Society for Quality of Life Research (ISOQOL) 24th Annual Conference, Philadelphia PA, Oct 18-21, 2017. Qual Life Res 26(1 Supplement):12-3, 2017. e-Pub 2017.
35. Shi Q, Massey RL, Shelton V, Wang XS. Patient-reported physical functioning impairment predicts delayed bowel movement and flatus after abdominal surgery [abstract]. Enhanced Recovery After Surgery (ERAS) 5th World Congress, Lyon, France, May 10-12, 2017, 2017. e-Pub 2017.
36. Wang XS, Williams LA, Shi Q, Garcia-Gonzalez AG, Kim BJ, Narula N, Davis CH, Aloia TA. A qualitative study for identifying symptom burden after liver surgery: MDASI-Hep development [abstract]. Enhanced Recovery After Surgery (ERAS) 5th World Congress, Lyon, France, May 10-12, 2017, 2017. e-Pub 2017.
37. Meyer LA, Shi Q, Iniesta MD, Harris M, Sun CC, Lasala J, Wang XS, Nick AM, Lu KH, Ramirez PT. Comparison of patient-reported symptom burden in patients with ovarian cancer undergoing primary vs. interval tumor-reductive surgery [abstract]. American Society of Clinical Oncology (ASCO) 53rd Annual Meeting, Chicago IL, Jun 2-6, 2017. J Clin Oncol 35(Suppl), 2017. e-Pub 2017.
38. Deng GE, Giralt S, Chung DJ, Landau HJ, Siman J, Search B, Coleton M, Vertosick E, Shapiro N, Chien C, Wang XS, Cassileth BR, Mao JJ. Acupuncture for symptom reduction in myeloma patients undergoing hematopoietic stem cell transplantation: a randomized, sham-controlled trial [abstract]. American Society of Clinical Oncology (ASCO) 53rd Annual Meeting, Chicago IL, Jun 2-6, 2017. J Clin Oncol 35(Suppl), 2017. e-Pub 2017.
39. Wang XS, Cleeland CS, Shi Q, Prasad S, Bokhari RH, Orlowski RZ. Minocycline to reduce cancer pain in patients with multiple myeloma: a Phase II randomized trial [abstract]. American Society of Clinical Oncology (ASCO) 53rd Annual Meeting, Chicago IL, Jun 2-6, 2017. J Clin Oncol 35(Suppl), 2017. e-Pub 2017.
40. Kukreja JB, Chang CM, Chen TY, Shi Q, Wang XS, Navai N, Kamat AM, Dinney CPN, Shah JB. Measuring and improving symptom burden in radical cystectomy patients undergoing traditional care compared to enhanced recovery [abstract]. American Society of Clinical Oncology (ASCO) 2017 Genitourinary Cancers Symposium, Orlando FL, Feb 16-18, 2017. J Clin Oncol 35(Suppl 6S), 2017. e-Pub 2017.
41. Mendoza T, Wang XS, Shi Q, Williams L, Ionova TI, Yun YH, Okuyama T, Cleeland CS. Do cancer patient's self-reports of symptom interference with functioning differ by culture or language? [abstract]. International Society for Quality of Life Research (ISOQOL) 23rd Annual Conference, Copenhagen, Denmark, Oct 19-22, 2016. Qual Life Res 25(1 Supplement):118-9, 2016. e-Pub 2016.
42. Wang XS, Shi Q, Yue J, Chen TY, Xu T, Komaki R, Gomez D, Cleeland CS, Mohan R, Liao ZX. Predictive value of patient-reported outcomes on radiation pneumonitis related normal lung uptake of FDG on PET in patients with non-small cell lung cancer treated with concurrent chemoradiation [abstract]. International Society for Quality of Life Research (ISOQOL) 23rd Annual Conference, Copenhagen, Denmark, Oct 19-22, 2016. Qual Life Res 25(1 Supplement):157-8, 2016. e-Pub 2016.
43. Lan M, Xu T, Yue J, Yang J, Gomez DR, Jeter MD, Nguyen QN, Shi Q, Hahn SM, Komaki R, Wang X, Liao Z. Polymorphisms of BMP4 and HIF-1A are associated with patient-reported symptoms in non-small-cell lung cancer patients treated with definitive chemoradiation therapy [abstract]. American Society for Radiation Oncology (ASTRO) 58th Annual Meeting, Boston MA, Sep 25-28, 2016. Int J Radiat Oncol Biol Phys 96(2 Supplement):S199, 2016. e-Pub 2016.
44. Meyer LA, Lasala J, Cain K, Shi Q, Wang XS, Earles T, Iniesta MD, Harris M, Gottumukkala V, Lu KH, Ramirez PT. Adoption of an enhanced recovery program leads to decreased patient reported opioid related adverse events [abstract]. International Society for Quality of Life Research (ISOQOL) 23rd Annual Conference, Copenhagen, Denmark, Oct 19-22, 2016. Qual Life Res 25(1 Supplement):119, 2016. e-Pub 2016.
45. Shi Q, Mendoza T, Wang XS, Cleeland CS. Responsiveness of patient-reported outcomes in measuring impairment of physical functioning related to cancer treatment [abstract]. International Society for Quality of Life Research (ISOQOL) 23rd Annual Conference, Copenhagen, Denmark, Oct 19-22, 2016. Qual Life Res 25(1 Supplement):81, 2016. e-Pub 2016.
46. Williams L, Mendoza TR, Shi Q, Wang XS, Haq S, Ali NN, Cleeland CS. Measuring treatment-induced peripheral neuropathy in patients with cancer: the Treatment-Induced Peripheral Neuropathy Scale (TNAS) [abstract]. Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) 2016 Annual Meeting, Adelaide, Australia, Jun 23-25, 2016. Support Care Cancer 24(Suppl 1):S133, 2016. e-Pub 2016.
47. George G, Iwuanyanwu EC, Yusuf A, Anderson KO, Piha-Paul SA, Naing A, Janku F, Subbiah V, Wang XS, Shi Q, Mendoza TR, Hong DS, Cleeland CS. Symptom clusters in patients with advanced cancer in an early-phase clinical trials clinic [abstract]. American Society of Clinical Oncology (ASCO) 52nd Annual Meeting, Chicago IL, Jun 3-7, 2016. J Clin Oncol 34(Suppl), 2016. e-Pub 2016.
48. Williams LA, Wang XS, Shi Q, Lin HK, Gonzalez G, Davis C, Cleeland CS, Orlowski R, Zyczynski TM. Patient-reported symptom burden in relapsed or refractory multiple myeloma [abstract]. American Society of Clinical Oncology (ASCO) 52nd Annual Meeting, Chicago IL, Jun 3-7, 2016. J Clin Oncol 34(Suppl), 2016. e-Pub 2016.
49. Wang XS, Fogelman D, Qiuling Shi Q, Mendoza T, Bokhari RH, Cleeland CS. Can minocycline ameliorate symptom burden in patients with pancreatic cancer? A Phase II randomized trial [abstract]. American Society of Clinical Oncology (ASCO) 52nd Annual Meeting, Chicago IL, Jun 3-7, 2016. J Clin Oncol 34(Suppl), 2016. e-Pub 2016.
50. Cleeland CS, Shi Q, Wang XS, Mendoza TR, Williams LA, Bokhari RH, Lin HK, Liao ZX. Minocycline to reduce chemoradiation-related fatigue in patients with non-small cell lung cancer: a Phase II randomized trial [abstract]. American Society of Clinical Oncology (ASCO) 52nd Annual Meeting, Chicago IL, Jun 3-7, 2016. J Clin Oncol 34(Suppl), 2016. e-Pub 2016.
51. Yue J, Xu T, Pan T, Jeter M, Nguyen Q, Levy LB, Shi Q, Komaki R, Gomez DR, Wang XS, Liao ZX. Normal-lung uptake of fluorodeoxyglucose, patient-reported symptoms, and clinician-rated radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation [abstract]. American Society of Clinical Oncology (ASCO) 52nd Annual Meeting, Chicago IL, Jun 3-7, 2016. J Clin Oncol 34(Suppl), 2016. e-Pub 2016.
52. Mendoza TR, Williams LA, Shi Q, Wang XS, Haq S, Ali NN, Cleeland CS. Measuring treatment-induced peripheral neuropathy in patients with cancer [abstract]. American Society of Clinical Oncology (ASCO) 52nd Annual Meeting, Chicago IL, Jun 3-7, 2016. J Clin Oncol 34(Suppl), 2016. e-Pub 2016.
53. Wang XS, Shi Q, Rice D, Vaporciyan A, Popat K, Cleeland CS. Patient-reported symptom interference as a measure of postsurgery functional recovery in lung cancer. Enhanced Recovery After Surgery (ERAS) 4th World Congress, Lisbon, Portugal, Apr 27-30, 2016, 2016. e-Pub 2016.
54. Williams LA, Haq S, Woodruff JF, Shi Q, Walsh DC, Meyer LA, Iniesta MD, Shah J, Gottumukkala V, Wang XS, Wood E. Using patient report to measure the effect of a perioperative enhanced recovery program on symptom burden [abstract]. The University of Texas System Shared Visions Conference, San Antonio TX, Apr 21-22, 2016, 2016. e-Pub 2016.
55. Wang XS, Shi Q, Rice DC, Vaporciyan A, Popat KU, Cleeland C. Patient-reported symptom interference as a measure of postsurgery functional recovery in lung cancer [abstract]. European Society of Parenteral and Enteral Nutrition (ESPEN) 38th Congress, Copenhagen, Denmark, Sep 17-20, 2016. Clinical Nutrition ESPEN 12(2016):e31, 2016. e-Pub 2016.
56. Bernstein MB, Chang EL, Amini B, Cabanillas M, Wang XS, Allen PK, Rhines L, Tatsui CE, Brown PD, Ghia AJ. Spine stereotactic radiosurgery for patients with metastatic thyroid cancer: secondary analysis of Phase I/II trials [abstract]. American Society for Radiation Oncology (ASTRO) 57th Annual Meeting, San Antonio TX, Oct 18-21, 2015. Int J Radiat Oncol Biol Phys 93(3 Supplement):E75-6, 2015. e-Pub 2015.
57. Shi Q, Mendoza TR, Wang XS, Cleeland CS. Determining meaningful cutpoints for the interference items of the MD Anderson Symptom Inventory [abstract]. International Society for Quality of Life Research (ISOQOL) 22nd Annual Conference, Vancouver BC, Oct 21-24, 2015. Qual Life Res 24(1 Supplement):48, 2015. e-Pub 2015.
58. Wang XS, Shi Q, H-K L, Li G, Williams LA, Orlowski RZ, Cleeland CS. Inflammatory gene SNPs as predictors of patient-reported symptom related functioning in patients with multiple myeloma [abstract]. International Society for Quality of Life Research (ISOQOL) 22nd Annual Conference, Vancouver BC, Oct 21-24, 2015. Qual Life Res 24(1 Supplement):1, 2015. e-Pub 2015.
59. Thomas SK, Mendoza TR, Dougherty PM, Williams LA, Wang XS, Prasad S, Shah N, Shah JJ, Wang M, Weber D, Orlowski RZ, Giralt S, Cleeland CS. A phase 2 trial of minocycline versus placebo to prevent neuropathy in patients (pts) with multiple myeloma (MM) [abstract]. American Society of Clinical Oncology (ASCO) 51st Annual Meeting, Chicago IL, May 29 - Jun 2, 2015. J Clin Oncol 33(Suppl), 2015. e-Pub 2015.
60. Wang XS, Shi Q, Cleeland CS, O'Reilly MS, Xu T, Bokhari RH, Gomez DR, Nguyen Q, Komaki R, Mohan R, Cox JD, Liao Z. Longitudinal study of pneumonitis and esophagitis-related symptoms in patients receiving concurrent chemoradiation for NSCLC [abstract]. American Society of Clinical Oncology (ASCO) 51st Annual Meeting, Chicago IL, May 29 - Jun 2, 2015. J Clin Oncol 33(Suppl), 2015. e-Pub 2015.
61. Wang XS, Shi Q, Rice DC, Vaporciyan A, Popat KU, Cleeland C. Using patient-reported outcomes to measure functional recovery after thoracic surgery [abstract]. World Congress of Enhanced Recovery After Surgery and Perioperative Medicine 2015, Washington DC, May 9-12, 2015. Can J Anesth 62(6):696, 2015. e-Pub 2015.
62. Meyer LA, Nick AN, Iniesta MD, Shi Q, Washington L, Harris M, Palmer LD, Cain KE, Earles TW, Lasala J, Wang XS, Ramirez PT. Comparison of patient-reported symptom burden pre- and post-implementation of an enhanced recovery pathway for gynecologic surgery [abstract]. World Congress of Enhanced Recovery After Surgery and Perioperative Medicine, Washington DC, May 9-12, 2015. Can J Anesth 62(6):683, 2015. e-Pub 2015.
63. Wang XS, Shi Q, Vernon SD. Ceiling effect limits utility of the Multidimensional Fatigue Inventory (MFI-20) to detect clinically meaningful fatigue in chronic fatigue syndrome [abstract]. International Society for Quality of Life Research (ISOQOL) 21st Annual Conference, Berlin, Germany, Oct 15-18, 2014. Qual Life Res 23(1 Supplement):127, 2014. e-Pub 2014.
64. Shi Q, Wang XS, Williams LA, Mendoza TR, Orlowski RZ, Cleeland CS. Measuring functional domains with the EORTC QLQ-C30 and MDASI in patients with cancer [abstract]. International Society for Quality of Life Research (ISOQOL) 21st Annual Conference, Berlin, Germany, Oct 15-18, 2014. Qual Life Res 23(1 Supplement):124, 2014. e-Pub 2014.
65. Gunn GB, Mendoza TR, Garden AS, Wang XS, Morrison WH, Frank SJ, Beadle BM, Phan J, Fuller CD, Chambers MS, Hanna EY, Lu C, Rosenthal DI, Cleeland CS. Minocycline for reduction of patient-reported symptoms during radiation therapy for head and neck cancer: first results of a randomized trial [abstract]. American Society of Clinical Oncology (ASCO) 50th Annual Meeting, Chicago IL, May 30 - Jun 3, 2014. J Clin Oncol 32(15 Suppl), 2014. e-Pub 2014.
66. Wang XS, Shi Q, Li D, Eng C, Bokhari RH, Fogelman DR. Inflammatory marker levels may predict patient-reported symptoms in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy [abstract]. American Society of Clinical Oncology (ASCO) 50th Annual Meeting, Chicago IL, May 30 - Jun 3, 2014. J Clin Oncol 32(15 Suppl), 2014. e-Pub 2014.
67. Thomas SK, Mendoza T, Dougherty PM, Williams L, Wang XS, Prasad S, Shah ND, Weber D, Wang M, Orlowski RZ, Giralt S, Cleeland C. A phase 2 trial of minocycline versus placebo to prevent neuropathy in patients (pts) with multiple myeloma (MM) [abstract]. American Society of Clinical Oncology (ASCO) 50th Annual Meeting, Chicago IL, May 30 - Jun 3, 2014. J Clin Oncol 32(15 Suppl), 2014. e-Pub 2014.
68. Shi Q, Wang XS, Shah ND, Orlowski RZ, Qazilbash MH, Williams LA, Mendoza TR, Cleeland CS. Prevalence of high symptom burden and its impact on functioning and quality of life in patients with multiple myeloma 3-9 months following autologous transplant [abstract]. American Society of Clinical Oncology (ASCO) 50th Annual Meeting, Chicago IL, May 30 - Jun 3, 2014. J Clin Oncol 32(15 Suppl), 2014. e-Pub 2014.
69. Shah N, Williams LA, Worthing A, Shi Q, Wang XS, Johnson V, Mendoza TR, Qazilbash MH, Champlin RE, Giralt SA, Cleeland CS. Higher stem cell dose infusion as rescue after intensive chemotherapy does not improve symptom burden in older patients with multiple myeloma and amyloidosis [abstract]. American Society of Hematology 55th Annual Meeting and Exposition, New Orleans LA, Dec 7-10, 2013. Blood 122(21), 2013. e-Pub 2013.
70. Shi Q, Wang XS, Li G, Cleeland CS. Using cluster analysis to generate outcome variables for gene-symptom association study in cancer patients [abstract]. International Society for Quality of Life Research (ISOQOL) 20th Annual Meeting, Miami FL, Oct 9-12, 2013. Qual Life Res 22(1 Suppl), 2013. e-Pub 2013.
71. Gunn GB, Mendoza TR, Fuller CD, Wang XS, Frank SJ, Hutcheson KA, Hanna EY, Garden AS, Cleeland CS, Rosenthal DI. Drivers of patient-reported symptom interference during radiation or chemoradiation as detected by the MD Anderson Symptom Inventory - Head and Neck Module [abstract]. American Society for Radiation Oncology (ASTRO) 55th Annual Meeting, Atlanta GA, Sep 22-25, 2013. Int J Radiat Oncol Biol Phys 87(2 Suppl):S116, 2013. e-Pub 2013.
72. Mendoza TR, Wang XS, Rhines LD, Selek U, Sharp HJ, Cleeland CS, Chang EL. The relationships of reduction in pain with other symptoms for cancer patients treated with stereotactic body radiation therapy [abstract]. International Society for Quality of Life Research (ISOQOL) 20th Annual Conference, Miami FL, Oct 9-12, 2013. Qual Life Res 22(1 Suppl):112, 2013. e-Pub 2013.
73. Wang XS, Dantzer R, Fuchs D, Eng C, Jing KY, Sailors M, Cleeland CS. Fatigue, affective symptom burden and altered tryptophan and phenylalanine metabolism in colorectal cancer patients undergoing chemotherapy [abstract]. Psychoneuroimmunology Research Society (PNIRS) 20th Annual Meeting, Stockholm, Sweden, Jun 5-8, 2013. Brain Behav Immun 32(Suppl):e36, 2013. e-Pub 2013.
74. Shi Q, Wang XS, Vaporciyan AA, David EA, Cleeland CS. Using time to pain recovery as an outcome measure for postoperative pain trials [abstract]. Division of Internal Medicine Research Retreat, The University of Texas MD Anderson Cancer Center, Houston TX, Jun 6-7, 2013, 2013. e-Pub 2013.
75. Escalante CP, Patlan JT, Manzullo EF, Wang X, Gao S, Row MB, Wang XS, Morrow PK, Richardson MN, Abisaaid Baker R, Yeung SJ. Fatigue in low-risk febrile neutropenia (FN) treated as outpatients (OPs) [abstract]. Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) 2013 International Symposium on Supportive Care in Cancer, Berlin, Germany, Jun 27-29, 2013. Support Care Cancer 21(Suppl 1):S203, 2013. e-Pub 2013.
76. Mendoza TR, Wang XS, Rhines LD, Selek U, Sharp HJ, Cleeland CS, Chang EL. The relationships of reduction in pain with other symptoms for cancer patients treated with stereotactic body radiation therapy [abstract]. American Society of Clinical Oncology 49th Annual Meeting, Chicago IL, May 31 - Jun 4, 2013. J Clin Oncol 31(15 Suppl), 2013. e-Pub 2013.
77. Shi Q, Wang XS, Reuben JM, Cohen EN, Williams LA, Mendoza TR, Sailors ML, Ilagan VM, Cleeland CS. Chemotherapy-induced peripheral neuropathy (CIPN) in patients with multiple myeloma undergoing maintenance therapy [abstract]. American Society of Clinical Oncology 49th Annual Meeting, Chicago IL, May 31 - Jun 4, 2013. J Clin Oncol 31(15 Suppl 1):611s, 2013. e-Pub 2013.
78. Wang XS, Liao Z, Komaki R, Cox JD, Gomez DR, Bokhari RH, Sailors ML, Cleeland CS. Patient-reported symptom burdens in NSCLC patients undergoing proton, 3DCRT or IMRT [abstract]. American Society of Clinical Oncology 49th Annual Meeting, Chicago IL, May 31 - Jun 4, 2013. J Clin Oncol 31(15 Suppl 1):476s, 2013. e-Pub 2013.
79. Jones D, Vichaya EG, Wang XS, Sailors MH, Mendoza TR, Williams LA, Cleeland CS, Wefel JS. Cognitive impariment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation [abstract]. MD Anderson 2013 Cancer Survivorship Research Retreat, "Cancer Survivorship: An Evolving Science," Houston TX, Feb 1, 2013, 2013. e-Pub 2013.
80. Jones D, Vichaya EG, Wefel JS, Thong MSY, Mendoza TR, Williams LA, Cleeland CS, Wang XS. Cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation [abstract]. American Society of Hematology 54th Annual Meeting and Exposition, Atlanta GA, Dec 8-11, 2012. Blood 120(21), 2012. e-Pub 2012.
81. Shi Q, Wang XS, Vaporciyan AA, David EA, Cleeland CS. Using time to symptomatic recovery as an outcome measure for perioperative pain study [abstract]. International Society for Quality of Life Research (ISOQOL) 19th Annual Conference, Budapest, Hungary, Oct 24-27, 2012, 2012. e-Pub 2012.
82. Wang XS, Shi Q, Shah N, Dantzer R, Johnson V, Reuben J, Cohen E, Ilagan V, Williams L, Cleeland C. Association between serum inflammatory markers and autologous stem cell transplant-induced sickness symptoms in patients with multiple myeloma [abstract]. Psychoneuroimmunology Research Society 19th Annual Meeting, San Diego CA, Jun 7-9, 2012. Brain Behav Immun 26(Suppl 1):S20, 2012. e-Pub 2012.
83. Cleeland CS, Wang XS, Thomas SK, Liu P, Sailors MH, Mendoza TR, Reuben JM, Cohen EN, Gilmore KR, Ilagan VM, Williams LA, Johnson VE. Predictive value of baseline serum MIP-1a and CRP on symptom burden and tumor response to induction therapy in patients with multiple myeloma [abstract]. American Society of Clinical Oncology 48th Annual Meeting, Chicago IL, Jun 1-5, 2012. J Clin Oncol 30(15 Suppl 1), 2012. e-Pub 2012.
84. Fogelman D, Wang XS, Vadhan S, Wolff R, Li D, Hassan M, Abbruzzese J. Can we identify patients with pancreatic cancer (PC) at high risk for cachexia? A prospective study [abstract]. Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) 2012 International Symposium on Supportive Care in Cancer, New York NY, Jun 28-30, 2012. Support Care Cancer 20(Suppl 1):S269, 2012. e-Pub 2012.
85. Escalante CP, Meyers CA, Reuben JM, Wang X, Qiao W, Manzullo EF, Alvarez RH, Morrow PKH, Gonzalez-Angulo AM, Mendoza TR, Wang XS, Liu W, Holmes HM, Hwang J, Pisters K, Overman MJ, Cleeland CS. A randomized, double blind, placebo-controlled crossover trial of a sustained release methylphenidate in cancer related fatigue [abstract]. American Society of Clinical Oncology 48th Annual Meeting, Chicago IL, Jun 1-5, 2012. J Clin Oncol 30(15 Suppl 1), 2012. e-Pub 2012.
86. Fisch M, Zhao F, O'Mara AM, Wang XS, Cella D, Cleeland CS. Determinants of fatigue improvement in outpatient oncology according to baseline categories of fatigue severity [abstract]. American Society of Clinical Oncology 48th Annual Meeting, Chicago IL, Jun 1-5, 2012. J Clin Oncol 30(15 Suppl 1), 2012. e-Pub 2012.
87. Jones D, Vichaya EG, Wang XS, Mendoza TR, Mobley GM, Lu C, Cleeland CS. Disease-driven symptoms and response to chemotherapy in treatment-naive patients with advanced non-small cell lung cancer (NSCLC) [abstract]. American Society of Clinical Oncology 48th Annual Meeting, Chicago IL, Jun 1-5, 2012. J Clin Oncol 30(15 Suppl 1), 2012. e-Pub 2012.
88. Vichaya EG, Wang XS, Boyette-Davis JA, He Z, Thomas SK, Shah N, Mendoza TR, Williams LA, Cleeland CS, Dougherty PM. Baseline subclinical sensory deficits and the development of pain and numbness in patients with multiple myeloma (MM) being treated with chemotherapy [abstract]. The University of Texas MD Anderson Cancer Center, Division of Internal Medicine Research Retreat, Houston TX, May 24, 2012, 2012. e-Pub 2012.
89. Valenzuela JO, Gning I, Irarrazaval ME, Fasce G, Marin L, Mendoza TR, Palos G, Reynolds R, Wang XS, Cleeland CS. Psychometric validation of the Spanish version of the Brief Fatigue Inventory [abstract]. The University of Texas MD Anderson Cancer Center, Division of Internal Medicine Research Retreat, Houston TX, May 24, 2012, 5/2012, 2012. e-Pub 2012.
90. Sailors MH, Wang XS, Liu P, Johnson VE, Reuben JM, Cohen EN, Williams LA, Mendoza TR, Cleeland CS. Longitudinal relationship between inflammatory markers and patient-reported symptom severity during induction therapy for multiple myeloma [abstract]. The University of Texas MD Anderson Cancer Center, Division of Internal Medicine Research Retreat, Houston TX, May 24, 2012, 2012. e-Pub 2012.
91. Jones D, Vichaya EG, Wang XS, Mendoza TR, Mobley GM, Lu C, Cleeland CS. Disease-driven symptoms and response to chemotherapy in treatment-naive patients with advanced non-small cell lung cancer (NSCLC) [abstract]. The University of Texas MD Anderson Cancer Center, Division of Internal Medicine Research Retreat, Houston TX, May 24, 2012, 2012. e-Pub 2012.
92. Thomas SK, Mendoza TR, Vichaya EG, Wang XS, Sailors MH, Williams LA, Dougherty PM, Cleeland CS. Validation of the Chemotherapy-Induced Neuropathy Assessment Scale [abstract]. American Society of Clinical Oncology 48th Annual Meeting, Chicago IL, Jun 1-5, 2012. J Clin Oncol 30(15 Suppl 1), 2012. e-Pub 2012.
93. Sailors MH, Wang XS, Liu P, Johnson VE, Reuben JM, Cohen EN, Williams LA, Mendoza TR, Cleeland CS. Longitudinal relationship between inflammatory markers and patient-reported symptom severity during induction therapy for multiple myeloma [abstract]. American Society of Clinical Oncology 48th Annual Meeting, Chicago IL, Jun 1-5, 2012. J Clin Oncol 30(15 Suppl 1), 2012. e-Pub 2012.
94. Shah N, Jones D, Mendoza TR, Williams LA, Wang XS, Vichaya EG, Sailors MH, Champlin RE, Cleeland CS. Validation of the M. D. Anderson Symptom Inventory mulitple myeloma module [abstract]. American Society of Clinical Oncology 48th Annual Meeting, Chicago IL, Jun 1-5, 2012. J Clin Oncol 30(15 Suppl 1), 2012. e-Pub 2012.
95. Vichaya EG, Wang XS, Boyette-Davis JA, He Z, Thomas SK, Shah N, Mendoza TR, Williams LA, Cleeland CS, Dougherty PM. Baseline subclinical sensory deficits and the development of pain and numbness in patients with multiple myeloma (MM) being treated with chemotherapy [abstract]. American Society of Clinical Oncology 48th Annual Meeting, Chicago IL, Jun 1-5, 2012. J Clin Oncol 30(15 Suppl 1), 2012. e-Pub 2012.
96. Wang XS, Zhao F, Fisch M, Mendoza TR, O'Mara AM, Cella D, Cleeland CS. Defining mild, moderate, and severe fatigue in cancer patients and survivors: (E2Z02) a trial of the eastern cooperative oncology group [abstract]. American Society of Clinical Oncology 48th Annual Meeting, Chicago IL, Jun 1-5, 2012. J Clin Oncol 30(15 Suppl 1), 2012. e-Pub 2012.
97. Williams LA, Wang XS, Johnson VE, Liu P, Shah N, Mendoza TR, Reuben JM, Cohen EN, Gilmore KR, Ilagan V, Cleeland CS. Inflammatory markers and symptom burden in patients with multiple myeloma undergoing autologous stem cell transplantation [abstract]. American Society of Clinical Oncology 48th Annual Meeting, Chicago IL, Jun 1-5, 2012. J Clin Oncol 30(15 Suppl 1), 2012. e-Pub 2012.
98. Wang XS, Fogelman DR, Shi Q, Eng C, Bokhari RH, Huang F, Mobley GM, Gilmore KR, Cleeland CS. Patient-reported symptoms from advanced pancreatic cancer patients undergoing gemcitabine-based chemotherapy [abstract]. American Society of Clinical Oncology 2012 Gastrointestinal Cancers Symposium, San Francisco CA, Jan 19-21, 2012. J Clin Oncol 30(4 Suppl), 2012. e-Pub 2012.
99. Wang XS, Shi Q, Cleeland CS, Mendoza TR, Williams L, Joy J, Ilagan VM, Mobley GM, Gilmore KR, Orlowski RZ. Development of patient-reported bortezomib-induced peripheral neuropathy in multiple myeloma patients undergoing induction therapy [abstract]. American Society of Hematology 53rd Annual Meeting and Exposition, San Diego CA, Dec 10-13, 2011. Blood 118(21):311, 2011. e-Pub 2011.
100. Valenzuela JO, Irarrazaval ME, Fasce G, Marin L, Palos G, Mendoza TR, Gning I, Reynolds R, Wang XS, Cleeland CS. Psychometric validation of the Spanish version of the M. D. Anderson Symptom Inventory (MDASI-Sp): multiple symptom assessment in cancer patients [abstract]. Cancer Prevention Research Institute of Texas (CPRIT) Annual Conference, Austin TX, Nov 15-17, 2011, 2011. e-Pub 2011.
101. Barney BJ, Mendoza TR, Cleeland CS, Johnson VE, Mobley GM, Lu C, Wang XS. Added prognostic benefit of various patient-reported outcomes for predicting overall survival in patients with advanced stage non-small cell lung cancer [abstract]. International Society for Quality of Life Research 18th Annual Conference, Denver CO, Oct 26-29, 2011, 2011. e-Pub 2011.
102. Mendoza TR, Michonski JD, Barney BJ, Wang XS, Lu C, Cleeland CS. Comparing the use of unique cutpoints against standard cutpoints when evaluating symptom burden [abstract]. International Society for Quality of Life Research 18th Annual Conference, Denver CO, Oct 26-29, 2011, 2011. e-Pub 2011.
103. Wang XS, Cleeland CS, Johnson VE, Reuben JM, Fogelman D, Malekifar M, Liao KP, Liu P, Cohen E, Lee BN, Gilmore KR, Eng C. sTNF-R1 and other cytokines associated with symptom burden related to chemotherapy in patients with colorectal cancer [abstract]. Psychoneuroimmunology Research Society 18th Annual Meeting, Chicago IL, Jun 8-11, 2011. Brain Behav Immun, 2011. e-Pub 2011.
104. Rosenthal DI, Gunn GB, Mendoza TR, Garden AS, Beadle BM, Morrison WH, Wang XS, Frank SJ, Weber RS, Ang KK, Cleeland CS. Long-term symptom burden after radiation treatment for oropharynx cancer: A comparison of 3D and IMRT techniques [abstract]. American Society of Clinical Oncology 47th Annual Meeting, Chicago IL, Jun 3-7, 2011. J Clin Oncol, 2011. e-Pub 2011.
105. Mendoza TR, Gunn GB, Fuller CD, Wang XS, Rosenthal DI, Cleeland CS. The utility of using area under the curve to analyze symptom burden during radiation/chemoradiation for head & neck cancer [abstract]. American Society of Clinical Oncology 47th Annual Meeting, Chicago IL, Jun 3-7, 2011. J Clin Oncol, 2011. e-Pub 2011.
106. Fogelman D, Wang XS, Vadhan-Raj S, Cleeland C, Hassan M, Morris J. Serum cytokines may outweigh clinical factors in predicting weight loss in advanced pancreatic cancer (PC) [abstract]. Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology 2011 International Symposium, Athens, Greece, Jun 23-25, 2011. Support Care Cancer 19(Suppl), 2011. e-Pub 2011.
107. Wang XS, Cleeland CS, Johnson VE, Reuben JM, Fogelman D, Malekifar M, Liao KP, Liu P, Cohen E, Lee BN, Ramsey KM, Eng C. Inflammatory cytokines and toxic effects of oxaliplatin-based chemotherapy in patients with colorectal cancer [abstract]. American Society of Clinical Oncology 47th Annual Meeting, Chicago IL, Jun 3-7, 2011. J Clin Oncol 29(15 Suppl), 2011. e-Pub 2011.
108. Wang XS, Eng C, Fogelman DR, Malekifar M, Liao KP, Glover KY, Cleeland CS. Self-report of neuropathy from oxaliplatin-based regimens in the treatment of colorectal cancer: with or without bevacizumab [abstract]. The University of Texas MD Anderson Cancer Center, Division of Internal Medicine Research Retreat, Houston TX, May 20, 2011, 2011. e-Pub 2011.
109. Wang XS, Cleeland CS, Johnson VE, Reuben JM, Fogelman D, Malekifar M, Liao KP, Liu P, Cohen E, Lee BN, Gilmore KR, Eng C. Inflammatory cytokines and toxic effects of oxaliplatin-based chemotherapy in patients with colorectal cancer [abstract]. The University of Texas MD Anderson Cancer Center, Division of Internal Medicine Research Retreat, Houston TX, May 20, 2011, 2011. e-Pub 2011.
110. Orlowski RZ, Wang XS, Mendoza TR, Williams LA, Johnson VE, Joy J, Ilagan V, Mobley GM, Liu P, Gilmore KR, Cleeland CS. Prevalence and trajectory of disease and treatment related symptom burden in multiple myeloma patients undergoing induction therapy [abstract]. American Society of Clinical Oncology 47th Annual Meeting, Chicago IL, Jun 3-7, 2011. J Clin Oncol 29(15 Suppl), 2011. e-Pub 2011.
111. Gunn GB, Mendoza TR, Garden AS, Wang XS, Morrison WH, Frank SJ, Hanna EY, Lu C, Beadle BM, Ang KK, Cleeland CS, Rosenthal DI. Patient-reported fatigue in head and neck cancer survivors [abstract]. American Society of Clinical Oncology 47th Annual Meeting, Chicago IL, Jun 3-7, 2011. J Clin Oncol 29(15 Suppl), 2011. e-Pub 2011.
112. Wang XS, Eng C, Fogelman D, Malekifar M, Liao KP, Glover K, Cleeland CS. Self report of neuropathy from oxaliplatin-based regimens in the treatment of colorectal cancer: with or without bevacizumab [abstract]. American Society of Clinical Oncology 2011 Gastrointestinal Cancers Symposium, San Francisco CA, Jan 20-22, 2011. J Clin Oncol 29(Suppl 4), 2011. e-Pub 2011.
113. Fogelman DR, Wang XS, Hassan M, Li D, Javle MM, Varadhachary GR, Shroff RT, Overman MJ, Wolff RA, Vadhan S, Abbruzzese JL. Relative value of serum cytokines and clinical factors in predicting weight loss in advanced pancreatic cancer (PC) [abstract]. American Society of Clinical Oncology 2011 Gastrointestinal Cancers Symposium, San Francisco CA, Jan 20-22, 2011. J Clin Oncol 29(Suppl 4), 2011. e-Pub 2011.
114. Rosenthal DI, Mendoza TR, Gunn GB, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Ang KK, Cleeland CS. Symptom burden during radiation therapy and chemoradiation for head and neck cancer [abstract]. American Society for Radiation Oncology 52nd Annual Meeting, San Diego CA, Oct 31 - Nov 4, 2010, 2010. e-Pub 2010.
115. Lee BN, Giralt S, Cohen E, Galland M, Lafortune T, Gning I, Mendoza TR, Williams L, Brown J, Wang XS, Champlin RE, Johnson VE, Cleeland CS, Reuben JM. Concordance between the serum levels of interleukin-6, microrna-21, and the severity of subjective symptoms of multiple myeloma patients undergoing autologous stem cell transplantation [abstract]. American Society of Hematology 2010 Annual Meeting, Orlando FL, Dec 4-7, 2010. Blood 116(21):1218, 2010. e-Pub 2010.
116. Mendoza TR, Gunn GB, Wang XS, Frank SJ, Beadle BM, Shah SJ, Lu C, Hanna EY, Cleeland CS, Rosenthal DI. Impact of symptom burden on survival in patients with head and neck cancer treated with definitive radiation therapy [abstract]. American Society for Radiation Oncology 52nd Annual Meeting, San Diego CA, Oct 31 - Nov 4, 2010, 2010. e-Pub 2010.
117. Mendoza TR, Wang XS, Palos G, Lu C, Liao Z, Mobley G, Kapoor S, Cleeland CS. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory (MDASI-LC) [abstract]. International Society for Quality of Life Research 17th Annual Conference, London, England, Oct 27-30, 2010. Qual Life Res 19(Suppl 1):18, 2010. e-Pub 2010.
118. Barney BJ, Johnson VE, Sheather SJ, Baladandayuthapani V, Wang XS, Cleeland CS. Longitudinal factor analysis of continuous and ordinal data [abstract]. 2010 Joint Statistical Meetings, Vancouver BC, Jul 31-Aug 5, 2010, 2010. e-Pub 2010.
119. Wang XS, Giralt SA, Williams LA, Shi Q, Mobley GM, Reuben JM, Lee BN, Cleeland CS. Measuring acute GVHD-related symptom burden and inflammatory cytokines during the first 100 days after allogeneic hematopoietic stem cell transplantation. Psychoneuroimmunology Research Society 17th Annual Meeting, Dublin, Ireland, Jun 2-5, 2010. Brain Behav Immun 24(Suppl 1):S5, 2010. e-Pub 2010.
120. Wang XS, Fogelman D, Eng C, Glover K, Malekifar M, Liao KP, Shah NA, Mendoza TR, Dougherty PM, Cleeland CS. Prospective study of paresthetic neurotoxicity from oxaliplatin-based regimens in the treatment of colorectal cancer [abstract]. American Society of Clinical Oncology 2010 Annual Meeting, Chicago IL, Jun 4-8, 2010. J Clin Oncol 28(15 Suppl):282s, 2010. e-Pub 2010.
121. Gunn GB, Mendoza TR, Wang XS, Garden AS, Lewin JS, Morrison WH, Frank SJ, Chambers MS, Cleeland CS, Rosenthal DI. The relationship of presenting symptom burden and survival in patients with head and neck cancer (HNC) [abstract]. American Society of Clinical Oncology 2010 Annual Meeting, Chicago IL, Jun 4-8, 2010. J Clin Oncol 28(15 Suppl):446s, 2010. e-Pub 2010.
122. Rosenthal DI, Mendoza TR, Gunn GB, Wang XS, Hessell AC, Garden AS, Morrison WH, Cleeland CS. The persistence of symptom burden after radiation treatment for head and neck cancer [abstract]. American Society of Clinical Oncology 2010 Annual Meeting, Chicago IL, Jun 4-8, 2010. J Clin Oncol 28(15 Suppl):439s, 2010. e-Pub 2010.
123. Palos GR, Mendoza TR, Liao KP, Garcia-Gonzalez A, Hahn K, Nazario A, Lynch GR, Anderson KO, Wang XS, Cleeland CS. Predictors of high symptom severity in caregivers of underserved minority cancer patients [abstract]. American Society of Clinical Oncology 2010 Annual Meeting, Chicago IL, Jun 4-8, 2010. J Clin Oncol 28(15 Suppl):660s, 2010. e-Pub 2010.
124. Cleeland CS, Mendoza TR, Palos GR, Lu C, Nazario A, Lynch GR, Mobley GM, Wang XS. Factors contributing to high symptom burden during chemotherapy for advanced lung cancer: the risk of being underserved [abstract]. American Society of Clinical Oncology 2010 Annual Meeting, Chicago IL, Jun 4-8, 2010. J Clin Oncol 28(15 Suppl):636s, 2010. e-Pub 2010.
125. Williams LA, Anderson KO, Wang XS, Cleeland CS, Mendoza TR, Mobley GM, Brown JO, Giralt S. Patterns of symptom burden in autologous and allogeneic hematopoietic stem cell transplantation [abstract]. American Society of Hematology 51st Annual Meeting and Exposition, New Orleans LA, Dec 5-8, 2009. Blood 114(22), 2009. e-Pub 2009.
126. Wang XS, Mendoza TR, Broadway JB, Mobley GM, Keating MJ, Cleeland CS, Ferrajoli A. Symptom profiles in patients with chronic lymphocytic leukemia: validation and application of the M. D. Anderson Symptom Inventory [abstract]. American Society of Hematology 51st Annual Meeting and Exposition, New Orleans LA, Dec 5-8, 2009. Blood 114(22), 2009. e-Pub 2009.
127. Wang XS, Johnson V, Williams LA, Mao L, Liao Z, Liu P, Cleeland CS. Serum sTNF-R1 and IL-6 are associated with severity of symptom burden caused by concurrent chemoradiation therapy for patients with lung and gastrointestinal cancers. 16th Annual Meeting of the Psychoneuroimmunology Research Society, Breckenridge CO, Jun 3-6, 2009. Brain Behav Immun 23(2 Suppl):S61-2, 2009. e-Pub 2009.
128. Wang XS, Williams LA, Johnson VE, Mao L, Krishnan S, Liao Z, Mobley G, Cleeland CS. Association of sTNF-R1 and the development of treatment-related symptoms in patients undergoing concurrent chemoradiation therapy for colorectal or esophageal cancer. American Society of Clinical Oncology 2009 Annual Meeting, Orlando FL, May 29 - Jun 2, 2009. J Clin Oncol 27(15 Suppl), 2009. e-Pub 2009.
129. Claassens L, van Meerbeeck J, Coens C, Quinten C, Wang XS, Velikova G, Bottomley A. Health-related quality of life (HRQOL) in non-small cell lung cancer (NSCLC): an update of a systematic review on methodological issues in randomized controlled trials (RCTs). American Society of Clinical Oncology 2009 Annual Meeting, Orlando FL, May 29 - Jun 2, 2009. J Clin Oncol 27(15 Suppl), 2009. e-Pub 2009.
130. Mendoza T, Rosenthal D, Wang X, Mobley G, Cleeland C. Measuring the symptom burden of head and neck cancer patients undergoing concurrent chemotherapy and radiation therapy using area under the curve. American Society of Clinical Oncology 2009 Annual Meeting, Orlando FL, May 29 - Jun 2, 2009. J Clin Oncol 27(15 Suppl), 2009. e-Pub 2009.
131. Martinelli F, Quinten C, Coens C, Flechtner H, Gotay C, Mendoza T, Osoba D, Reeve B, Wang X, Bottomley A. Relationships among health-related quality-of-life indicators in cancer patients: a pooled study of baseline EORTC QLQ-C30 data from 6,739 patients. American Society of Clinical Oncology 2009 Annual Meeting, Orlando FL, May 29 - Jun 2, 2009. J Clin Oncol 27(15 Suppl), 2009. e-Pub 2009.
132. Palos GR, Wang XS, Garcia-Gonzalez A, Liao KP, Ramsey KM, Mobley G, Balderas L, Nazario A, Hahn K, Lynch GR, Hurley J, Cleeland CS. Underserved and undertreated: the symptom experience of advanced lung cancer patients treated at public hospitals. The University of Texas M. D. Anderson Cancer Center Division of Internal Medicine Research Retreat, Houston TX, Apr 17, 2009, 2009. e-Pub 2009.
133. Palos GR, Wang XS, Garcia-Gonzalez A, Liao KP, Ramsey KM, Mobley G, Balderas L, Nazario A, Hahn K, Lynch GR, Hurley J, Cleeland CS. Underserved and undertreated: tracking advanced lung cancer symptoms in patients treated at inner-city public hospitals. Tenth National Conference on Nursing Research, Orlando FL, Feb 13, 2009, 2009. e-Pub 2009.
134. Williams LA, Giralt SA, Wang XS, Mobley GM, Mendoza TR, Cohen MZ, Cleeland CS. Measuring symptom burden of allogeneic hematopoietic stem cell transplantation in patients with and without acute graft-versus-host disease. American Society for Blood and Marrow Transplantation 2009 BMT Tandem Meetings, Tampa FL, Feb 11-15, 2009. Biol Blood Marrow Transplant 15(2 Suppl):20-1, 2009. e-Pub 2009.
135. Williams LA, Ault P, Wang XS, Cleeland CS, Mendoza TR, Mobley GM, Cortes JE. The symptom burden of chronic myeloid leukemia (CML). [abstract]. American Society of Hematology 50th Annual Meeting and Exposition, San Francisco CA, Dec 6-9, 2008. Blood 112(11), 2008. e-Pub 2008.
136. Wang XS, Shi Q, Williams LA, Mobley GM, Reuben JM, Lee BN, Cleeland CC, Giralt SA. The role of serum cytokines in the development of acute-GVHD–related symptom burden after allogeneic hematopoietic stem cell transplantation. European Hematology Association 13th Congress, Copenhagen, Denmark, 2008. e-Pub 2008.
137. Wang XS, Giralt S, Shi Q, Williams L, Reuben J, Cleeland C. Serum interleukin (IL)-6 and sTNF-R1 are associated with development of multiple symptoms during first 30 days of allogeniec hematopoietic stem cell transplantation. 2008 Annual Meeting of the Psychoneuroimmunology Research Society (PNIRS). Brain Behav Immun 22(4 Suppl 1):32, 2008. e-Pub 2008.
138. Wang XS, Shi Q, Mao L, Cleeland CS, Liao Z. Association between inflammatory cytokines and the development of multiple symptoms in patients with non-small cell lung cancer undergoing chemoradiation therapy. American Society of Clinical Oncology 44th Annual Meeting, Chicago IL. J Clin Oncol 26(15 Suppl), 2008. e-Pub 2008.
139. Cleeland CS, Vaporciyan A, Shi Q, Gning I, Johnson BA, Mendoza T, Wang XS. A computerized telephone monitoring and alert system to reduce postoperative symptoms: a randomized trial. American Society of Clinical Oncology 44th Annual Meeting, Chicago IL. J Clin Oncol 26(15 Suppl), 2008. e-Pub 2008.
140. Palos GR, Garcia-Gonzalez A, Ramsey KM, Liao KP, Sanchez MG, Mobley GM, Nazario A, Mendoza TR, Wang XS, Cleeland CS, Anderson KO, McCurdy SA. It's a rough ride: the caregiver experience when the patient is underserved and undertreated [abstract]. The University of Texas MD Anderson Cancer Center Division of Internal Medicine Research Retreat, Houston TX, Apr 25, 2008, 2008. e-Pub 2008.
141. Novik AA, Ionova TI, Kalyadina SA, Kishtovich AV, Cleeland CS, Wang XS. The value of pain assessment in cancer pain management. International Society for Quality of Life Research 14th Annual Conference, Toronto ON, Canada, October 10-13, 2007. Qual Life Res Supplement:A54, 2007. e-Pub 2007.
142. Kalyadina SA, Novik AA, Ionova TI, Kishtovich AV, Kopp MV, Wang XS, Cleeland CS. Symptoms and their management in advanced cancer patients. European Society for Medical Oncology 2007 Conference Lugano (ECLU), Lugano, Switzerland. Ann Oncol 18(Suppl 9):195-6, 2007. e-Pub 2007.
143. Nejmi M, Gning I, Wang XS, Mendoza TR, Cleeland CS. Validation of the Arabic Version of the M. D. Anderson Symptom Inventory (MDASI-A). European Association for Palliative Care 10th Congress, Budapest, Hungary, 2007. e-Pub 2007.
144. Wang XS, Lu C, Shi Q, Fairclough DL, Mobley GM, Palos GR, Mendoza TR, Cleeland CS. Symptom burden and survival outcome: 3 cycles vs 6 cycles of chemotherapy in advanced NSCLC. American Society of Clinical Oncology 43rd Annual Meeting, Chicago IL. J Clin Oncol 25(18 Suppl), 2007. e-Pub 2007.
145. Mendoza TR, Wang XS, Mobley G, Palos G, Cleeland CS. The adequacy of pain treatment in advance stage non-small cell lung cancer: a longitudinal study. American Society of Clinical Oncology 43rd Annual Meeting, Chicago IL. J Clin Oncol 25(18 Suppl), 2007. e-Pub 2007.
146. Cleeland CS, Shi Q, Lu C, Johnson V, Mendoza TR, Palos GR, Mobley GM, Wang XS. Palliative chemotherapy and cancer-related fatigue in patients with advanced non-small cell lung cancer. American Society of Clinical Oncology 43rd Annual Meeting, Chicago IL. J Clin Oncol 25(18 Suppl), 2007. e-Pub 2007.
147. Krishnan S, Mendoza T, Zhang Y, Wang XS, Das P, Delclos ME, Crane C, Cleeland C, Janjan N. Prevalence and temporal patterns of persistence of symptoms in 165 rectal cancer patients receiving preoperative chemoradiation therapy. American Society of Clinical Oncology 43rd Annual Meeting, Chicago IL. J Clin Oncol 25(18 Suppl), 2007. e-Pub 2007.
148. Novik AA, Ionova TI, Kalyadina SA, Kishtovich AV, Fedorenko DA, Wang XS, Cleeland CS. National multi-center epidemiological study on prevalence and treatment of cancer-related symptoms. American Society of Clinical Oncology 43rd Annual Meeting, Chicago IL. J Clin Oncol 25(18 Suppl), 2007. e-Pub 2007.
149. Zinner R, Fossella FV, Kies MS, Herbst RS, Lu C, Johnson FM, Bhat SV, Price JS, Cleeland C, Wang X. A phase II trial of pemetrexed (P) in patients (pts) with performance status (PS) 2 and 3 as first- and second-line treatment for advanced non-small cell lung cancer (NSCLC). American Society of Clinical Oncology 43rd Annual Meeting, Chicago IL. J Clin Oncol 25(18 Suppl), 2007. e-Pub 2007.
150. Wang XS, Shi Q, Williams LA, Giralt SA, Cleeland CS. The role of serum cytokines in the development of fatigue during allogeneic hematopoietic stem cell transplantation. European Hematology Association 12th Congress, Vienna, Austria. Haematologica 92(Suppl 1):288, 2007. e-Pub 2007.
151. Janjan NA, Wang XS, Mendoza TR, Zhang Y, Das P, Crane C, Delclos M, Krishnan S, Cleeland CS. Utility of the M. D. Anderson Symptom Inventory (MDASI) for symptom evaluation during chemoradiation in patients with gastrointestinal malignancies. American Society of Clinical Oncology 43rd Annual Meeting, Chicago IL. J Clin Oncol 25(18 Suppl), 2007. e-Pub 2007.
152. Palos GR, Shi Q, Mendoza TR, Mobley GM, Zhang Y, Valero V, Hurley J, Wang XS, Cleeland CS. Differences in lung cancer symptom severity by tertiary cancer center vs. centers treating underserved patients. American Society of Clinical Oncology 43rd Annual Meeting, Chicago IL, June 1-5, 2007. J Clin Oncol 25(18 Suppl), 2007. e-Pub 2007.
153. Ionova TI, Novik AA, Kalyadina SA, Kishtovich AV, Wang XS, Cleeland CS. National multicenter epidemiological study on prevalence and treatment of cancer-related symptoms. International Society for Quality of Life Research 13th Annual Conference, Lisbon, Portugal, October 10-14, 2006. Qual Life Res 15(Suppl 1):A6, 2006. e-Pub 2006.
154. Mendoza TR, Rosenthal DI, Asper JA, Garden AS, Chambers MS, Ahamad A, Kies MS, Gning I, Wang X, Cleeland CS. The M. D. Anderson Symptom Inventory-Head & Neck (MDASI-HN) is a sensitive, clinically useful outcome measure for the burden of radiation-induced mucositis and the impact of its prevention or treatment. American Society for Therapeutic Radiology and Oncology 48th Annual Meeting, Philadelphia PA. Int J Radiat Oncol Biol Phys 66(3 Suppl 1):538-9, 2006. e-Pub 2006.
155. Wang XS, Williams LA, Shi Q, Giralt S, Cleeland CS. Baseline inflammatory cytokines predicted rapid increase in symptom severity to nadir of allogeneic BMT. American Society of Hematology 48th Annual Meeting, Orlando FL. Blood 108(11):845A-6A, 2006. e-Pub 2006.
156. Williams LA, Wang XS, Giralt SA, Mobley GM, Cleeland CS. Symptom burden for patients undergoing allogeneic blood or marrow transplantation for AML/MDS [abstract]. Division of Internal Medicine Research Retreat, The University of Texas M. D. Anderson Cancer Center, Houston TX, May 2006, 2006. e-Pub 2006.
157. Novik A, Ionova T, Kalyadina S, Kishtovich A, Wang XS, Cleeland CS. Ongoing national multi-center epidemiological study on prevalence and treatment of cancer-related symptoms in Russia. European Association for Palliative Care 4th Research Forum, Venice, Italy, May 25-27, 2006. Palliat Med 20(3):244, 2006. e-Pub 2006.
158. Wang XS, Zhao Y, Li P. A survey of the use of traditional Chinese medicine for cancer patients in China. NCCAM Conference: Traditional Chinese Medicine and Cancer Research: Fostering Collaborations, Advancing the Science, Washington DC, 2006. e-Pub 2006.
159. Williams L, Wang XS, Cleeland C, Giralt S. Symptom burden in patients undergoing allogeneic blood or marrow transplantation for AML/MDS. Oncology Nursing Society 31st Annual Congress, Boston MA. Oncol Nurs Forum 33(2):410, 2006. e-Pub 2006.
160. Giralt S, Cleeland CS, Reuben J, Lee BN, Williams LA, Mobley G, Wang XS. Measuring multiple symptoms and inflammatory cytokines related to acute GVHD in AML/MDS patients undergoing allogeneic BMT. American Society of Blood and Marrow Transplantation 2006 BMT Tandem Meeting, Honolulu HI. Biol Blood Marrow Transplant 12(2 Suppl 1):5-6, 2006. e-Pub 2006.
161. Wang XS, Cleeland CS, Williams LA, Reuben J, Lee BN, Mobley G, Giralt S. Longitudinal assessment of inflammatory cytokines and symptom severity during first 100 days after allogeneic BMT for AML/MDS patients. American Society for Blood and Marrow Transplantation 2006 BMT Tandem Meeting, Honolulu HI. Biol Blood Marrow Transplant 12(2 Suppl 1):23, 2006. e-Pub 2006.
162. Williams LA, Wang XS, Cleeland CS, Mobley G, Giralt S. Assessment of symptoms and symptom burden before and after engraftment during allogeneic blood or marrow transplant (BMT). American Society for Blood and Marrow Transplantation 2006 BMT Tandem Meeting, Honolulu HI. Biol Blood Marrow Transplant 12(2 Suppl 1):135, 2006. e-Pub 2006.
163. Wang XS, Fairclough DL, Liao Z, Komaki R, Chang JY, Cleeland CS. Mixed effects model of cancer-related symptoms in NSCLC patients under chemoradiation therapy. International Society for Quality of Life Research 12th Annual Conference, San Francisco CA, October 19-22, 2005. Qual Life Res 14(9):2041, 2005. e-Pub 2005.
164. Williams LA, Wang XS, Cleeland CS, Mobley G, Giralt S. Assessment of symptoms and symptom burden before and after engraftment during allogeneic blood or marrow transplant (BMT). American Society of Hematology 47th Annual Meeting, Atlanta GA. Blood 106(11):384A, 2005. e-Pub 2005.
165. Wang XS, Ferrajoli A, Broadway JB, Mobley GM, Mendoza TR, Keating MJ, Cleeland C. Symptom assessment in patients with chronic lymphocytic leukemia: validation and application of the M. D. Anderson Symptom Inventory. American Society of Hematology 47th Annual Meeting, Atlanta GA. Blood 106(11):331B, 2005. e-Pub 2005.
166. Wang XS, Cleeland CS, Williams LA, Reuben JM, Lee BN, Mobley G, Giralt S. Longitudinal assessment of inflammatory cytokines and symptom severity during 100 days of allogeneic BMT for AML/MDS patients. American Society of Hematology 47th Annual Meeting, Atlanta GA. Blood 106(11):221B, 2005. e-Pub 2005.
167. Giralt S, Cleeland CS, Reuben J, Lee BN, Williams LA, Mobley G, Wang XS. Measuring multiple symptoms and inflammatory cytokines related to acute GVHD in AML/MDS patients undergoing allogeneic BMT. American Society of Hematology 47th Annual Meeting, Atlanta GA. Blood 106(11):412A, 2005. e-Pub 2005.
168. Lee BN, Camacho LH, Mendoza T, Anderson KO, Lance CG, Wang XS, Cleeland CS, Reuben JM. Cytokines in interferon-alpha therapy induced sleep disturbance of patients with malignant melanoma. The International Society for Interferon and Cytokine Research 2005 Annual Meeting, Shanghai, China, 2005. e-Pub 2005.
169. Chang EL, Shiu A, Rhines L, Mathews L, Allen P, Mahajan A, Woo S, Gning I, Wang XS, Brown B, Cleeland C, Mendel E. Interim results of a phase I/II evaluation of stereotactic body radiotherapy for spinal metastases. American Society for Therapeutic Radiology And Oncology 47th Annual Meeting, Denver CO. Int J Radiat Oncol Biol Phys 63(2 Suppl 1):S68-9, 2005. e-Pub 2005.
170. Williams LA, Wang XS, Cleeland CS, Mobley G, Giralt S. Assessment of symptoms and symptom burden before and after engraftment during allogeneic blood and marrow transplant (BMT) [abstract]. Young Investigators Research Forum, The University of Texas MD Anderson Cancer Center, Houston TX, Sep 12, 2005, 2005. e-Pub 2005.
171. Wang XS, Janjan NA, Liao Z, Komaki R, Mendoza TR, Cleeland CS. Longitudinal model for pain and other cancer-related symptoms during radiotherapy. International Association for the Study of Pain 11th World Congress, Sydney, Australia, 2005. e-Pub 2005.
172. Rosenthal DI, Chambers MS, Mendoza TR, Asper JA, Kies MS, Weber RS, Garden AS, Ang KK, Wang XS, Cleeland CS. The reliability and validity of the M. D. Anderson Symptom Inventory (MDASI-HN) as a measure of symptom burden in the head and neck cancer (HNC) patient population. American Society of Clinical Oncology 41st Annual Meeting, Orlando FL. J Clin Oncol 23(16S):753, 2005. e-Pub 2005.
173. Shih YCT, Cantor SB, Wang XS, Cleeland CS. Deriving a preference-based index from the M. D. Anderson Symptom Inventory in cancer patients. International Society for Pharmacoeconomics and Outcomes Research 10th Annual International Meeting, Washington DC. Value in Health 8(3):351-2, 2005. e-Pub 2005.
174. Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y. Comparison of the performance of four cancer-related fatigue instruments: validation study of the Japanese version of the Brief Fatigue Inventory. Academy of Psychosomatic Medicine 51st Annual Meeting, Marco Island FL. Psychosomatics 46(2):163, 2005. e-Pub 2005.
175. Fedorenko DA, Kishtovich AV, Ionova TI, Novik AA, Wang XS, Cleeland CS. The use of the Brief Fatigue Inventory in systemic rheumatic patients. International Society for Quality of Life Research 11th Annual Conference, Hong Kong, 2004. e-Pub 2004.
176. Wang XS, Giralt SA, Warneke C, Ensor J, Mendoza TR, Anderson KO, Cleeland CS. Mixed effects modeling of the relationship of cytokines and symptom severity in patients during first 30 days of autologous BMT. International Society for Quality of Life Research 2004 Symposium - Stating the Art: Advancing Outcomes Research Methodology and Clinical Applications, Boston MA, 2004. e-Pub 2004.
177. Wang XS, Giralt SA, Warneke CL, Mendoza TR, Albitar M, Brown JO, Anderson KO, Cleeland CS. Longitudinal assessment of IL-6 and symptom severity in multiple myeloma patients during first 30 days of autologous BMT. American Society of Clinical Oncology 40th Annual Meeting, New Orleans LA. J Clin Oncol 22(14S):191, 2004. e-Pub 2004.
178. Shevchenko J, Novik A, Lyadov K, Wang X, Mendoza T, Cleeland C, Ionova T, Kishtovich A, Kalyadina S. Utility of the Brief Pain Inventory. Negative pain management index and its predictors: the Russian experience. European Association for Palliative Care 3rd Research Forum, Stresa, Italy, June 3-6 2004. Palliat Med 18(4):381, 2004. e-Pub 2004.
179. Wang XS, Putnam JB, Johnson BA, Warneke CL, Cleeland CS. Longitudinal study of pain and other symptoms after thoracic surgery for cancer. American Pain Society 23rd Annual Scientific Meeting (American Pain Society and Canadian Pain Society 2nd Joint Scientific Meeting), Vancouver BC. J Pain 5(3 Suppl):S50, 2004. e-Pub 2004.
180. Jeon Y, Wang X, Guo H, Jones P, Cleeland C. Clinicians' practice and attitude of cancer pain management in Korea. American Pain Society 23rd Annual Scientific Meeting (American Pain Society and Canadian Pain Society 2nd Joint Scientific Meeting), Vancouver BC. J Pain 5(3 Suppl):S121, 2004. e-Pub 2004.
181. Reyes-Gibby CC, Anderson KO, Mendoza TR, Wang XS, Cleeland CS. Symptom burden in community-dwelling adults. The University of Texas M. D. Anderson Cancer Center 2nd Annual Conference on Mechanisms and Treatment of Cancer-related Symptoms, Houston TX, 2004. e-Pub 2004.
182. Ionova TI, Novik AA, Manikhas GV, Wang XS, Mendoza TR, Kalyadina SA, Ivanova MO, Uspenskaya OS, Kishtovich AV, Cleeland CS. Validation of Russian versions of Brief Pain Inventory (BPI-R), Brief Fatigue Inventory (BFI-R) and M. D. Anderson Symptom Inventory (MDASI-R) to assess symptoms in cancer patients. International Society for Quality of Life Research 10th Annual Conference, Prague, Czech Republic, November 12-15, 2003. Qual Life Res 12(7):798, 2003. e-Pub 2003.
183. Ionova TI, Novik AA, Wang XS, Mendoza TR, Kalyadina SA, Ivanova MO, Uspenskaya OS, Kishtovich AV, Cleeland CS. Symptom severity and prevalence in advanced cancer patients: the Russian experience. International Society for Quality of Life Research 10th Annual Conference, Prague, Czech Republic, November 12-15, 2003. Qual Life Res 12(7):818, 2003. e-Pub 2003.
184. Anderson KO, Giralt SA, Neumann JL, Warneke CL, Mendoza TR, Brown JO, Smith S, Wang XS, Cleeland CS. Symptom assessment following autologous transplantation: relation of symptom severity to laboratory measures. American Society of Hematology 45th Annual Meeting and Exposition, San Diego CA. Blood 102(11):987A, 2003. e-Pub 2003.
185. Wang XS, Giralt S, Mendoza TR, Brown BW, Albitar M, Brown JO, Anderson KO. Longitudinal assessment of inflammatory cytokines: symptom severity during autologous BMT. American Society of Hematology 45th Annual Meeting and Exposition, San Diego CA. Blood 102(11):488B, 2003. e-Pub 2003.
186. Wang XS, Putnam JB, Johnson BA, Mobley G, Cleeland CS. Pain severity and satisfaction of pain control post-thoracic surgery. International Society for Quality of Life Research Annual Conference, Prague, Czech Republic, 2003. e-Pub 2003.
187. Lee BN, Andersson B, Cohen MZ, Mendoza T, de Lima MJ, Couriel DR, Brown BW, Wang XS, Cleeland CS, Giralt S, Champlin RE, Reuben JM. Relationship between plasma cytokine levels and self-reported symptoms in AML patients pre- and post-transplantation with allogeneic peripheral blood stem cells. American Society of Hematology 45th Annual Meeting and Exposition, San Diego CA. Blood 102(11):966A, 2003. e-Pub 2003.
188. Safdar A, Torres I, Mendoza T, Wang XS, Jones PH, Cleeland CS, Rolston KV. Management of infection in patients with advanced cancer in Latin America: Medical Oncology Survey Report 2001. Infectious Diseases Society of America 41st Annual Meeting, San Diego CA, 2003. e-Pub 2003.
189. Novik AA, Manikhas G, Ionova T, Wang XS, Mendoza T, Kalyadina S, Ivanova M, Uspenskaya O, Kishtovich A, Cleeland C. Symptom prevalence, severity, and pain management index in advanced cancer patients: the Russian experience. American Society of Clinical Oncology 39th Annual Meeting, Chicago IL, 2003. e-Pub 2003.
190. Wang XS, Yen NP, Duc NB, Jones PH, Magruder E, Cleeland CS. Survey on cancer pain management among Vietnam clinicians. American Pain Society 22nd Annual Scientific Meeting, Chicago IL. J Pain 4(2 Suppl), 2003. e-Pub 2003.
191. Ionova T, Wang XS, Kalyadina S, Guo H, Mendoza T, Manikhas G, Novik A, Cleeland CS. Validation of the Russian version of the Brief Pain Inventory (BPI-R) in Russian cancer patients. American Pain Society 22nd Annual Scientific Meeting, Chicago IL. J Pain 4(2 Suppl), 2003. e-Pub 2003.
192. Palmer SN, Wang XS, Johnson BA, McCrory L, Jr PJ, Mobley G, Henke S, Cleeland CS. Attitudes about pain medication predict pain ratings in the acute postoperative period. American Pain Society 22nd Annual Scientific Meeting, Chicago IL. J Pain 4(2 Suppl), 2003. e-Pub 2003.
193. Johnson BA, McCrory L, Wang XS, Palmer SN, Mobley G, Henke SC, Putnam JB, Cleeland CS. Patients can accurately recall satisfaction with in-hospital pain control at one month post-thoracotomy. American Pain Society 22nd Annual Meeting, Chicago IL. J Pain 4(2 Suppl), 2003. e-Pub 2003.
194. Anderson KO, Mendoza TR, Wang XS, Cleeland CS. Pain and sleep disturbance among cancer outpatients. American Pain Society 22nd Annual Scientific Meeting, Chicago IL. J Pain 4(2 Suppl), 2003. e-Pub 2003.
195. Novik AA, Manikhas G, Ionova T, Wang XS, Chekrizov S, Fridman M, Mendoza T, Karyagin E, Kalyadina S, Ivanova M, Uspenskaya O, Kishtovich A, Cleeland CS. Comparison of symptom severity and prevalence between hematological malignancies and solid tumors among Russian oncology patients. American Society of Hematology 44th Annual Meeting and Exposition, Philadelphia PA. Blood 100(11):496B, 2002. e-Pub 2002.
196. Mendoza T, Cleeland C, Wang S, Brown T, Lin E, Wolff R, Janjan N. Differences in quality of life during chemoradiation for rectal and pancreatic cancers: measurable impact of chemotherapy on treatment-related toxicities. Radiological Society of North America 88th Scientific Assembly and Annual Meeting, Chicago IL. Radiology 225:510, 2002. e-Pub 2002.
197. Wang XS, Johnson MM, Broemeling LD, Janjan N, Komaki R, Mendoza T, Cleeland CS. Longitudinal model for cancer-related symptoms during radiotherapy among patients with gastrointestinal and lung cancer. International Society for Quality of Life Research 9th Annual Congress, Orlando FL, 2002. e-Pub 2002.
198. Reyes-Gibby CC, Wang XS, Mendoza TR, Morrissey M, Wendt J, Anderson KO, Cleeland CS. Impact of pain on fatigue: community-dwelling and cancer patient populations. International Association for the Study of Pain 10th World Congress on Pain, San Diego CA, 2002. e-Pub 2002.
199. Nejmi M, Wang XS, Mendoza T, Gning I, Cleeland CS. The preliminary validation study of the Arabic version of the Brief Pain Inventory (BPI-A). International Association for the Study of Pain 10th World Congress on Pain, San Diego CA, 2002. e-Pub 2002.
200. Torres I, DeLima L, Wang XS, Zhang Q, Mendoza TR, Jones P, Cleeland CS. The availability of supportive cancer care services and medications in Latin America: preliminary findings from a survey of healthcare professionals. International Association for the Study of Pain 10th World Congress on Pain, San Diego CA, 2002. e-Pub 2002.
201. Lee JQ, Escalante CP, Mendoza T, Wang XS, Johnson BA, Guo H, Simmonds MJ, Cleeland C. Assessing the factor structure of the functional status index in patients with cancer-related fatigue. Third Annual Research Conference on Cancer-Related Fatigue and Related Symptoms, Houston TX, 2002. e-Pub 2002.
202. Torres I, Wang XS, DeLima L, Jones P, Palos G, Mendoza T, Cleeland CS. Physicians' perceptions of barriers to optimal cancer pain management: preliminary findings of a survey on advanced cancer care in Latin America and the Caribbean. American Pain Society 21st Annual Meeting, Baltimore MD. J Pain 3(2 Suppl), 2002. e-Pub 2002.
203. Wang XS, Torres I, DeLima L, Jones P, Cleeland CS. Physicians' self-reported competency on pain and symptom management in Latin America and the Caribbean. American Pain Society 21st Annual Meeting, Baltimore MD. J Pain 3(2 Suppl), 2002. e-Pub 2002.
204. Anderson KO, Beattie-Palmer L, Brown JO, Mobley G, Mendoza T, Wang XS, Neumann JL, Giralt S, Cleeland CS. Monitoring pain during the first six months following autologous transplantations using an interactive voice response system. American Pain Society 21st Annual Meeting, Baltimore MD. J Pain 3(2 Suppl), 2002. e-Pub 2002.
205. Mendoza TR, Anderson KO, Wang XS, Easley M, Mobley G, Cleeland CS. Phone it in or fill it in? Comparing symptom assessment using the interactive voice response system with the traditional paper and pencil method. International Society for Quality of Life Research Annual Meeting, Amsterdam, The Netherlands, 2001. e-Pub 2001.
206. Mendoza TR, Wang XS, Harle M, Reyes-Gibby C, Cleeland CS. Survival, quality of life, and the severity of symptoms of cancer patients. International Society for Quality of Life Research Annual Meeting, Amsterdam, The Netherlands, 2001. e-Pub 2001.
207. Wang XS, Janjan NA, Komaki R, Easley M, Mendoza TR, Mobley G, Cleeland CS. Symptoms predict reduced HRQL during radiotherapy among patients with lung, colorectal, and pancreatic cancer. International Society for Quality of Life Research Annual Meeting, Amsterdam, The Netherlands, 2001. e-Pub 2001.
208. Wang XS, Giralt S, Engstrom MC, Mendoza TR, Johnson BA, Peterson N, Cleeland CS. Factors associated with cancer-related fatigue in patients with leukemia and non-Hodgkin's lymphoma: epidemiology of symptoms of cancer and cancer-related treatment. American Public Health Association 129th Annual Meeting, Atlanta GA, 2001. e-Pub 2001.
209. Torres I, Wang XS, Palos G, Jones P, Gning I, DeLima L, Mendoza T, Cleeland CS. Advanced cancer care in Latin America and Caribbean: a survey of health professionals. American Public Health Association 129th Annual Meeting, Atlanta GA, 2001. e-Pub 2001.
210. Reyes-Gibby CC, Mendoza TR, Wang XS, Easley MK, Mobley G, Cleeland CS. Symptoms and their impact on quality of life among cancer patients receiving radiation therapy. American Public Health Association 129th Annual Meeting, Atlanta GA, 2001. e-Pub 2001.
211. Easley MK, Anderson KO, Wang XS, Beattie-Palmer L, Brown JO, Mobley G, Cleeland CS. Symptom tracking using interactive voice response technology. American Public Health Association 129th Annual Meeting, Atlanta GA, 2001. e-Pub 2001.
212. Reyes-Gibby CC, Cleeland CS, Wang X, Easley M, Mobley G, Mendoza T, Janjan N. Symptom patterns and their impact on the quality of life among patients receiving radiotherapy. American Society of Clinical Oncology 37th Annual Meeting, San Francisco CA, 2001. e-Pub 2001.
213. Wang XS, Janjan N, Komaki R, Easley M, Mendoza T, Mobley G, Cleeland CS. Cancer-related fatigue is the most severe symptom during radiation therapy among patients with lung, colorectal, and pancreatic cancer. American Society of Clinical Oncology 37th Annual Meeting, San Francisco CA, 2001. e-Pub 2001.
214. Easley MK, Anderson KO, Wang XS, Beattie-Palmer L, Brown JO, Mobley G, Cleeland CS. Symptom tracking with interactive voice response: a new tool for clinicians and researchers. American Society of Clinical Oncology 37th Annual Meeting, San Francisco CA, 2001. e-Pub 2001.
215. Wang XS, Guo H, Tiao K, Cleeland CS. Improving cancer pain management for Chinese-American patients. American Pain Society 20th Annual Scientific Meeting, Phoenix AZ. J Pain 2(2 Suppl), 2001. e-Pub 2001.
216. Wang XS, Tang J, Zhang M, Guo H, Cleeland CS. Pain management for pediatric oncology: practice and attitude in Chinese pediatricians. American Pain Society 20th Annual Scientific Meeting, Phoenix AZ. J Pain 2(2 Suppl), 2001. e-Pub 2001.
217. De los Santos J, Janjan N, Brown T, Hoff P, Wolff R, Simicrope F, Skibber J, Feig B, Ellis L, Hunt K, Curley S, Bisanz A, Evettts P, Allen P, Wiatrek R, Mendoza T, Wang S, Cleeland C, Crane C. Response of disease-related symptoms to preoperative chemoradiation for locally advanced rectal cancer. Radiological Society of North America 86th Scientific Assembly and Annual Meeting, Chicago IL, 2000. e-Pub 2000.
218. Callister M, Janjan N, Brown T, Hoff P, Wolff R, Sinicrope F, Skibber J, Feig B, Ellis L, Hunt K, Curley S, Bisanz A, Evetts P, Allen P, Wiatrek R, Mendoza T, Wang S, Cleeland C, Crane C, Sanfilippo N. Effective management of treatment-related enteritis during preoperative chemoradiation for locally advanced rectal cancer. American Society for Therapeutic Radiology and Oncology 42nd Annual Meeting, Boston MA. Int J Radiat Oncol Biol Phys 48(1):225-226, 2000. e-Pub 2000.
219. Wang XS, Liu SJ, Di LJ, Bruera E, Cleeland CS. Advanced cancer care issues in China. American Society of Clinical Oncology 36th Annual Meeting, New Orleans LA, 2000. e-Pub 2000.
220. Ren XS, Wang XS, Liu S, Hao X. Psychometric and clinical evaluation of the Chinese version of the SF-36 health survey among cancer patients in China. International Society for Quality of Life Research Annual Meeting, Vancouver BC, 2000. e-Pub 2000.
221. Wang XS, Liu SJ, Cleeland CS. A survey of Chinese physician attitudes and practice on cancer pain management. Multinational Association of Supportive Care in Cancer 12th International Symposium: Supportive Care in Cancer, Washington DC, 2000. e-Pub 2000.
222. Anderson KO, Mendoza TR, Harle M, Chou C, Cohen MZ, Wang XS, Cleeland CS. Relationship of pain to symptom severity, ood, and quality of life in cancer patients undergoing blood or marrow transplantations. American Pain Society 18th Annual Scientific Meeting, Fort Lauderdale FL, 1999. e-Pub 1999.
223. Wang XS, Yu SY, Engstrom MC, Cleeland CS. Cancer pain management in a Chinese general hospital: an evaluation of physicians attitude and practice. American Pain Society 18th Annual Scientific Meeting, Fort Lauderdale FL, 1999. e-Pub 1999.

Book Chapters

1. Beeler DM, Wang XS. Integrative approaches to fatigue. In: Comprehensive Integrative Oncology. 1st. Academic Press, 349-361, 2026.
2. Wang, XS, Shi, Q. Symptom Assessment, Patient-Reported Outcomes, and Quality of Life Considerations in Perioperative Care for Patients With Cancer, 566-574, 2023.
3. Wang XS. Cancer-related fatigue. In: Principles and Practice of Palliative Care and Supportive Oncology. 4th. Wolters Kluwer/Lippincott Williams & Wilkins, 84-95, 2013.
4. Wang XS. Cancer-related fatigue: clinical science. In: Cancer Symptom Science: Measurement, Mechanisms, and Management. Cambridge University Press, 110-23, 2011.
5. Escalante CP, Wang XS. Cancer-related fatigue. In: Medical Care of Cancer Patients. BC Decker, 53-59, 2009.
6. Wang XS, Cleeland CS. Outcomes measurement in cancer pain. In: Pain Management: Evidence, Outcomes, and Quality of Life. A Sourcebook. Elsevier, 361-76, 2007.
7. Fairclough DL, Wang XS. Understanding the correlation between biologic and symptom measures over time. In: Advancing Health Outcomes Research Methods and Clinical Applications. Degnon Associates, 177-190, 2005.
8. Wang XS. Cancer pain management in China: a personal narrative. In: Narrative, Pain, and Suffering. IASP Press, 167-176, 2005.
9. Wang XS. Pain and traditional Chinese medicine. In: Il Dolore Inutile: La Pena in Più del Malato. Garzani Libri s.p.a, 371-376, 2002.
10. Wang XS. Cancer-related fatigue. In: Principles and Practice of Palliative Care and Supportive Oncology. 5. Wolters Kluwer/Lippincott Williams & Wilkins.
11. Wang XS. Symptom assessment, PROs, and QoL considerations in the cancer patient in perioperative care for patients with cancer. In: Perioperative Care in Cancer Patient.

Letters to the Editor

1. Hirata Y, Lyu H, Smith GL, Wang XS, Tran Cao HS, Katz MHG, Ikoma N. What Defines the Value of Minimally Invasive Surgery for Cancer Patients?. Ann Surg Oncol 31: 2204-2207, 2024.